Abstract
Germ cell tumors (GCT) of the ovary and other locations in the female genital tract are analyzed from a clinicopathological viewpoint and reconsidered in the light of the latest genetic knowledge of their origin and information from new pluripotency and developmental stage markers.
Ovarian malignant primitive GCT have a well-defined phenotype. The expression of characteristic pluripotency markers in dysgerminoma is useful in the diagnosis of its various histologic variants, including artifacts. Dysgerminoma has a pure germ cell origin, in contrast to yolk sac tumors (YST), which may develop at any age from both germ and somatic cells at various stages of pluripotentiality. The histologically heterogeneous YST are reconsidered as primitive endodermal tumors applying a diagnostic immunohistochemical panel able to distinguish between extraembryonal and somatic variants.
Type II GCT of postpubertal testicular type such as embryonal carcinoma, mixed GCT, and choriocarcinomas are rare in females; they often occur associated with disorders of sex development.
Ovarian mature teratomas are the paradigm of a parthenogenetic origin (type IV), and their morphology and complications are exhaustively reviewed. Prognostically relevant histologic grading of immature are reanalyzed, taking into account the presence of immature endodermal structures and expression of pluripotency markers SALL4 and SOX2.
An emerging category of highly malignant GCT originating from somatic Müllerian tumors in older patients (endometrioid carcinomas and clear cell tumor) is considered. They probably arise from induced pluripotential tumor stem cells (type VI GCT) and often represent a diagnostic challenge. The comparative immunophenotypic expression of various pluripotency and tissue-specific proteins is a useful tool for their identification.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
Marsden HB, Birch JM, Swindell R. Germ cell tumours of childhood: a review of 137 cases. J Clin Pathol. 1981;34(8):879–83.
Katsube Y, Berg JW, Silverberg SG. Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol. 1982;1(1):3–16.
Lo Curto M, D’Angelo P, Cecchetto G, Klersy C, Dall’Igna P, Federico A, et al. Mature and immature teratomas: results of the first paediatric Italian study. Pediatr Surg Int. 2007;23(4):315–22. doi:10.1007/s00383-007-1890-1.
Quirk JT, Natarajan N, Mettlin CJ. Age-specific ovarian cancer incidence rate patterns in the United States. Gynecol Oncol 2005;99(1):248–50. doi:S0090-8258(05)00506-8 [pii] 10.1016/j.ygyno.2005.06.052.
Moller H, Evans H. Epidemiology of gonadal germ cell cancer in males and females. APMIS 2003;111(1):43–6; discussion 6–8. doi:apm1110107 [pii].
Lee ST, Choi MH, Lee EJ, Gong SP, Jang M, Park SH et al. Establishment of autologous embryonic stem cells derived from preantral follicle culture and oocyte parthenogenesis. Fertil Steril 2008;90(5):1910–20. doi:S0015-0282(07)00207-5 [pii] 10.1016/j.fertnstert.2007.01.099.
Oliveira FG, Dozortsev D, Diamond MP, Fracasso A, Abdelmassih S, Abdelmassih V et al. Evidence of parthenogenetic origin of ovarian teratoma: case report. Hum Reprod 2004;19(8):1867–70. doi:10.1093/humrep/deh345. deh345 [pii].
Weiss JR, Burgess JR, Kaplan KJ. Fetiform teratoma (homunculus). Arch Pathol Lab Med 2006;130(10):1552–6. doi:CR51040 [pii] 10.1043/1543-2165(2006)130[1552:FTH]2.0.CO;2.
Sheikine Y, Genega E, Melamed J, Lee P, Reuter VE, Ye H. Molecular genetics of testicular germ cell tumors. Am J Cancer Res. 2012;2(2):153–67.
Goodman S, Zhang L, Cheng L, Jiang Z. Differential expression of IMP3 between male and female mature teratomas–immunohistochemical evidence of malignant nature. Histopathology. 2014;65(4):483–9. doi:10.1111/his.12409.
Sigismondi C, Scollo P, Ferrandina G, Candiani M, Angioli R, Vigano R, et al. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 Retrospective Study. Int J Gynecol Cancer. 2015;25(2):203–7. doi:10.1097/IGC.0000000000000358.
Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol. 2007;16(3) doi:10.1016/j.suronc.2007.07.005.
Gobbi D, Fascetti Leon F, Aquino A, Melchionda F, Lima M. Metachronous bilateral ovarian teratoma: a germ-line familial disorder and review of surgical management options. J Pediatr Adolesc Gynecol 2013;26(5):e105–7. doi:10.1016/j.jpag.2013.02.006. S1083-3188(13)00102-2 [pii].
Galani E, Alamanis C, Dimopoulos MA. Familial female and male germ cell cancer. A new syndrome? Gynecol Oncol 2005;96(1):254–5. doi:S0090-8258(04)00802-9 [pii] 10.1016/j.ygyno.2004.09.047.
Giambartolomei C, Mueller CM, Greene MH, Korde LA. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol 2009;33(1):31–6. doi:10.1016/j.canep.2009.04.015. S1877-7821(09)00038-1 [pii].
Stevens LC, Varnum DS. The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev Biol. 1974;37(2):369–80. doi:0012-1606(74)90155-9 [pii].
Prat J, Cao D, Carinelli SG, Nogales FF, Vang R, Zaloudek CJ. Germ cell tumours. In:WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. p. 57–62.
Nogales FF, Dulcey I, Preda O. Germ cell tumors of the ovary: an update. Arch Pathol Lab Med. 2014;138(3):351–62. doi:10.5858/arpa.2012-0547-RA.
Prat J, Cao D, Carinelli SG, Nogales FF, Vang R, Zaloudek CJ. World health organization classification of tumours In: Kurman RY, Young RH. editor. Tumours of the female genital organs. 2nd ed. Lyon: IARCPress; 2014.
Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075–85. doi:107/5/1075 [pii] 10.1097/01.AOG.0000216004.22588.ce.
Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992–1999. Gynecol Oncol 2005;97(2):519–23. doi: S0090-8258(05)00123-X [pii] 10.1016/j.ygyno.2005.02.007.
Arora RS, Alston RD, Eden TO, Geraci M, Birch JM. Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer. 2012;118(17):4290–7. doi:10.1002/cncr.27403.
Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, et al. Gonadal and extragonadal germ cell tumours in the United States, 1973–2007. Int J Androl. 2012;35(4):616–25. doi:10.1111/j.1365-2605.2011.01245.x.
Pierce GB, Speers WC. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res. 1988;48(8):1996–2004.
Nogales FF. Haines & Taylor obstetrical and gynaecological pathology. In: Fox H, Wells M, editors. Haines & Taylor obstetrical and gynaecological pathology. 5th ed. Edinburgh: Churchill Livingstone; 2003. p. 771–820.
Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005;18 Suppl 2:S61–79. doi:3800310 [pii] 10.1038/modpathol.3800310.
Prat JC, D, Carinelli SG, Nogales FF, Vang R, Zaloudek CJ, International Agency for Research on Cancer., World Health Organization. WHO classification of tumours of female reproductive organs. World Health Organization classification of tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2014. p. 57–62.
Oliva H, Young RH. Germ cell tumours of the ovary: selected topics. Diagnostic Histopathol. 2014;20(9):364–375.
Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev 2008;34(5):427–41. doi:10.1016/j.ctrv.2008.02.002. S0305-7372(08)00025-X [pii].
Lee KH, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009;19(1):84–7. doi:10.1111/IGC.0b013e31819914c5. 00009577-200901000-00016 [pii].
Vazquez I, Rustin GJ. Current controversies in the management of germ cell ovarian tumours. Curr Opin Oncol 2013;25(5):539–45. doi:10.1097/01.cco.0000432609.39293.77. 00001622-201309000-00014 [pii].
Gershenson DM. Treatment of ovarian cancer in young women. Clin Obstet Gynecol. 2012;55(1):65–74. doi:10.1097/GRF.0b013e318248045b. 00003081-201203000-00008 [pii].
Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25(20):2938–43. doi:25/20/2938 [pii] 10.1200/JCO.2007.10.8738.
Solheim O, Gershenson DM, Trope CG, Rokkones E, Sun CC, Weedon-Fekjaer H et al. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978–2010). Eur J Cancer 2014;50(11):1942–50. doi:10.1016/j.ejca.2014.03.288. S0959-8049(14)00573-5 [pii].
Mangili G, Sigismondi C, Lorusso D, Cormio G, Scollo P, Vigano R et al. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. Gynecol Oncol 2011;121(2):280–4. doi:10.1016/j.ygyno.2011.01.006. S0090-8258(11)00018-7 [pii].
Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25(19):2792–7. doi:25/19/2792 [pii] 10.1200/JCO.2006.08.4590.
Solheim O, Trope CG, Rokkones E, Kaern J, Paulsen T, Salvesen HB et al. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the “cisplatin era”. Gynecol Oncol 2015;136(2):224–9. doi:10.1016/j.ygyno.2014.12.010 S0090-8258(14)01565-0 [pii].
Cossu-Rocca P, Zhang S, Roth LM, Eble JN, Zheng W, Karim FW et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol 2006;19(4):611–5. doi:3800576 [pii] 10.1038/modpathol.3800576.
Cheng L, Roth LM, Zhang S, Wang M, Morton MJ, Zheng W, et al. KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer. 2011;117(10):2096–103. doi:10.1002/cncr.25794.
Meyer R. Ovarialtumoren und Geschlechtlichkeit. Ein Beitrag zur funktionellen Betrachtung der Geschwülste: I.“Disgerminome” beider Geschlechter bei Störung in der Entwicklung der Keimdrüsen, II. Granulosazelltumoren mit “Verweiblichung,” III. Arrhenoblastome mit “Vermännlichung”. Klin Wochenschr. 1930;9:2237–40.
Stewart CJ, Baker E, Beaton C, Crook M, Peverall J, Wallace S. Detection of Y-chromosome in gonadal tumours using fluorescence in situ hybridization: diagnostic value in intersex conditions including older patients with clinically unsuspected androgen insensitivity syndrome. Histopathology 2008;52(2):175–82. doi:10.1111/j.1365-2559.2007.02927.x. HIS2927 [pii].
Boyes DA, Pankratz E, Walliford BW, White GW, Fairey RN. Experience with dysgerminomas at the Cancer Control Agency of British Columbia. Gynecol Oncol. 1978;6(2):123–9.
Linton EB. Dysgerminoma of the ovary. J Reprod Med. 1981;26(5):255–60.
Kraggerud SM, Szymanska J, Abeler VM, Kaern J, Eknaes M, Heim S, et al. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res. 2000;60(11):3025–30.
Zhao S, Kato N, Endoh Y, Jin Z, Ajioka Y, Motoyama T. Ovarian gonadoblastoma with mixed germ cell tumor in a woman with 46, XX karyotype and successful pregnancies. Pathol Int. 2000;50(4):332–5. doi:pin1041 [pii]
Koo YJ, Chun YK, Kwon YS, Lee IH, Kim TJ, Lee KH, et al. Ovarian gonadoblastoma with dysgermi-noma in a woman with 46XX karyotype. Pathol Int. 2011;61(3):171–3. doi:10.1111/j.1440-1827.2010.02636.x.
Tanaka Y, Fujiwara K, Yamauchi H, Mikami Y, Kohno I. Pregnancy in a woman with a Y chromosome after removal of an ovarian dysgerminoma. Gynecol Oncol 2000;79(3):519–21. doi:10.1006/gyno.2000.6004. S0090-8258(00)96004-9 [pii].
Paliwal P, Sharma A, Birla S, Kriplani A, Khadgawat R. Identification of novel SRY mutations and SF1 (NR5A1) changes in patients with pure gonadal dysgenesis and 46, XY karyotype. Mol Hum Reprod 2011;17(6):372–8. doi:10.1093/molehr/gar002 gar002 [pii].
Rozenholc A, Abdulcadir J, Pelte MF, Petignat P. A pelvic mass on ultrasonography and high human chorionic gonadotropin level: not always an ectopic pregnancy. BMJ Case Rep. 2012;2012. doi:10.1136/bcr.01.2012.5577 bcr0120125577 [pii] bcr.01.2012.5577 [pii].
Brettell JR, Miles PA, Herrera G, Greenberg H. Dysgerminoma with syncytiotrophoblastic giant cells presenting as a hydatidiform mole. Gynecol Oncol. 1984;18(3):393–401.
Nourani M, Manera RB. Pediatric ovarian dysgerminoma presenting with hypercalcemia and chronic constipation: a case report. J Pediatr Hematol Oncol. 2013;35(7):e272–3. doi:10.1097/MPH.0b013e31829bcaf1.
Rotman M, Dorfmann H, de Seze S, Kahn MF. Coexistence d’un lupus erythemateux disseminé et d’un seminome de l’ovarie. Guérison apparente rapide du lupus après ablation de la tumeur. Recul de 7 ans. Nouv Press Med. 1972;1(13):853–7.
Yeh KE, Marcus PS, Fong TL. Paraneoplastic cholestasis associated with ovarian dysgerminoma. Obstet Gynecol. 2015;126(2):431–4. doi:10.1097/AOG.0000000000000699.
Buskirk SJ, Schray MF, Podratz KC, Lee RA, Stanhope CR, Gaffey TA, et al. Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clin Proc. 1987;62(12):1149–57.
De Palo G, Lattuada A, Kenda R, Musumeci R, Zanini M, Pilotti S, et al. Germ cell tumors of the ovary: the experience of the National Cancer Institute of Milan. I. Dysgerminoma. Int J Radiat Oncol Biol Phys. 1987;13(6):853–60. doi:0360-3016(87)90099-X [pii].
Schweyer S, Soruri A, Baumhoer D, Peters J, Cattaruzza M, Radzun HJ, et al. Expression of CXC chemokine IP-10 in testicular germ cell tumours. J Pathol. 2002;197(1):89–97. doi:10.1002/path.1094.
Kato N, Kurotaki H, Uchigasaki S, Fukase M, Kurose A. Ovarian clear cell carcinoma with plasma cell-rich inflammatory stroma: a clear cell carcinoma subgroup with distinct clinicopathological features. Histopathology. 2015; doi:10.1111/his.12783.
Sellami-Dhouib R, Nasfi A, Mejri NT, Doghri R, Charfi L, Sassi S, et al. Ovarian ALK+ diffuse large B-cell lymphoma: a case report and a review of the literature. Int J Gynecol Pathol. 2013;32(5):471–5. doi:10.1097/PGP.0b013e31826cbd6e.
Alvarado-Cabrero I, Valencia-Cedillo R, Mohs-Alfaro M, De Anda-Gonzalez J. Ovarian dysgerminoma associated with fibrosarcoma: a case report. Int J Gynecol Pathol. 2011;30(5):466–9. doi:10.1097/PGP.0b013e318217139e.
Iczkowski KA, Butler SL, Shanks JH, Hossain D, Schall A, Meiers I et al. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol 2008;39(2):275–81. doi:S0046-8177(07)00357-7 [pii] 10.1016/j.humpath.2007.07.002.
Idrees M, Saxena R, Cheng L, Ulbright TM, Badve S. Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4. Ann Diagn Pathol 2010;14(5):331–6. doi:10.1016/j.anndiagpath.2010.05.008 S1092-9134(10)00095-X [pii].
Chang MC, Vargas SO, Hornick JL, Hirsch MS, Crum CP, Nucci MR. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol. 2009;28(4):347–55. doi:10.1097/PGP.0b013e318195da86.
Rijlaarsdam MA, van Herk HA, Gillis AJ, Stoop H, Jenster G, Martens J et al. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours. Br J Cancer 2011;105(6):854–63. doi:10.1038/bjc.2011.270 bjc2011270 [pii].
Cossu-Rocca P, Jones TD, Roth LM, Eble JN, Zheng WX, Karim FWA, et al. Cytokeratin and CD30 expression in dysgerminoma. Hum Pathol. 2006;37(8):1015–21. doi:10.1016/j.humpath.2006.02.018.
Battifora H, Sheibani K, Tubbs RR, Kopinski MI, Sun TT. Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma. Cancer. 1984;54(5):843–8.
Parkash V, Carcangiu ML. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum. Mod Pathol. 1995;8(8):881–7.
Tatekawa Y, Kemmotsu H, Mouri T, Joe K, Ohkawa H. A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase. J Pediatr Surg. 2004;39(9):1437–9. doi:S0022346804003628 [pii].
Nogales FF, Ruiz Avila I, Concha A, del Moral E. Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry. Hum Pathol. 1993;24(4):364–70.
Young RH. A brief history of the pathology of the gonads. Mod Pathol. 2005;18:S3–S17. doi:10.1038/modpathol.3800305.
Young RH. The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by It-Gunnar Teilum and Aleksander Talerman-and the bond it formed between them. Int J Surg Pathol 2014;22(8):677–87. doi:10.1177/1066896914558265 1066896914558265 [pii].
Nogales FF, Preda O, Nicolae A. Yolk sac tumours revisited. A review of their many faces and names. Histopathology. 2012;60(7):1023–33. doi:10.1111/j.1365-2559.2011.03889.x.
Nogales FF, Talerman A, Kubik-Huch RA, Tavassoli FA, Devousssoux-Shisheboran M. Germ cell tumours In: Tavassoli FA, P Devilee, Eds. Tumours of the breast and female genital tract. Lyon: IARC Press; 2003. p. 163–75.
Mosbech CH, Rechnitzer C, Brok JS, Rajpert-De Meyts E, Hoei-Hansen CE. Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors. J Pediatr Hematol Oncol. 2014;36(4):263–70. doi:10.1097/MPH.0000000000000125.
Simon RA, Laughlin TS, Nuccie B, Wang N, Rothberg PG, Wang X. A 46 XY phenotypic female adolescent with bilateral gonadal tumors consisting of five different components. Int J Gynecol Pathol 2008;27(3):407–11. doi:10.1097/PGP.0b013e31815d05d4 00004347-200807000-00013 [pii].
Langley FA, Govan AD, Anderson MC, Gowing NF, Woodcock AS, Harilal KR. Yolk sac and allied tumours of the ovary. Histopathology. 1981;5(4):389–401.
Cooper C, Cooper M, Carter J, Russell P. Gonadoblastoma progressing to dysgerminoma in a 55-year-old woman with normal karyotype. Pathology 2007;39(2):284–5. doi:773354847 [pii] 10.1080/00313020701230708.
Nogales FF, Bergeron C, Carvia RE, Alvaro T, Fulwood HR. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol. 1996;20(9):1056–66.
Roth LM, Talerman A, Levy T, Sukmanov O, Czernobilsky B. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component. Int J Gynecol Pathol. 2011;30(5):442–51. doi:10.1097/PGP.0b013e3182164386.
Elhosseiny A, Gonzalez O, Hedjazi M, Pillari V, Howard R. Endodermal sinus tumor and benign cystic teratoma of the ovary occurring simultaneously. N Y State J Med. 1989;89(4):233–4.
Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976;38(6):2404–19.
Arima N, Tanimoto A, Hayashi R, Hamada T, Sasaguri Y. Ovarian yolk sac tumor with virilization during pregnancy: Immunohistochemical demonstration of Leydig cells as functioning stroma. Pathol Int. 2000;50(6):520–5. doi:10.1046/j.1440-1827.2000.01073.x.
Pecorelli S, Sartori E, Favalli G, Ugazio AG, Gastaldi A. Ataxia-telangiectasia and endodermal sinus tumor of the ovary: report of a case. Gynecol Oncol. 1988;29(2):240–4. doi:0090-8258(88)90219-3 [pii].
Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children’s Oncology Group. J Clin Oncol 2014;32(5):465–70. doi:10.1200/JCO.2013.51.1006 JCO.2013.51.1006 [pii].
Mooney EE, Nogales FF, Tavassoli FA. Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells. Hum Pathol. 1999;30(6):611–7.
Williams SD, Einhorn LH. Brain metastases in disseminated germinal neoplasms: incidence and clinical course. Cancer. 1979;44(4):1514–6.
Clement PB, Young RH, Scully RE. Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. Am J Surg Pathol. 1987;11(10):767–78.
Nogales Jr FF, Matilla A, Nogales O, galera-Davidson HL. Yolk sac tumors with pure and mixed polyvesicular vitelline patterns. Hum Pathol. 1978;9(5):553–66.
Young RH, Ulbright TM, Policarpio-Nicolas MLC. Yolk sac tumor with a prominent polyvesicular vitelline pattern a report of three cases. Am J Surg Pathol. 2013;37(3):393–8. doi:10.1097/Pas.0b013e31827dcc2b.
Vos A, Oosterhuis JW, de Jong B, Castedo SM, Hollema H, Buist J, et al. Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor. Cancer Genet Cytogenet. 1990;44(2):223–8. doi:0165-4608(90)90051-B [pii].
Vandeputte M, Sobis H. Experimental rat model for human yolk sac tumor. Eur J Cancer Clin Oncol. 1988;24(3):551–8.
Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol. 1986;10(3):151–64.
Damjanov I, Amenta PS, Zarghami F. Transformation of an AFP-positive yolk sac carcinoma into an AFP-negative neoplasm. Evidence for in vivo cloning of the human parietal yolk sac carcinoma. Cancer. 1984;53(9):1902–7.
Nogales-Fernandez F, Silverberg SG, Bloustein PA, Martinez-Hernandez A, Pierce GB. Yolk sac carcinoma (endodermal sinus tumor): ultrastructure and histogenesis of gonadal and extragonadal tumors in comparison with normal human yolk sac. Cancer. 1977;39(4):1462–74.
Kao CS, Idrees MT, Young RH, Ulbright TM. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases. Am J Surg Pathol. 2012;36(3):360–7. doi:10.1097/PAS.0b013e31823c510b.
Kao CS, Idrees MT, Young RH, Ulbright TM. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases. Am J Surg Pathol. 2012;36(3):360–7.
Nogales FF, Quinonez E, Lopez-Marin L, Dulcey I, Preda O. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac. Histopathology. 2014;65(1):51–9. doi:10.1111/his.12373.
Heifetz SA, Cushing B, Giller R, Shuster JJ, Stolar CJ, Vinocur CD, et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children’s Cancer Group. Am J Surg Pathol. 1998;22(9):1115–24.
Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer. 1982;50(11):2355–68.
Salazar HK, Tobon, A. et al. Endodermal cell derivatives in embryonal carcinoma of the ovary: an electron microscopy study of two cases. Am J Pathol. 1974;74:108a.(abstr).
Michael H, Ulbright TM, Brodhecker CA. The pluripotential nature of the mesenchyme-like component of yolk sac tumor. Arch Pathol Lab Med. 1989;113(10):1115–9.
Nogales FF, Buritica C, Regauer S, Gonzalez T. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors. Am J Surg Pathol. 2005;29(9):1247–51. doi:00000478-200509000-00017 [pii].
Dickersin GR, Oliva E, Young RH. Endometrioid-like variant of ovarian yolk sac tumor with foci of carcinoid: an ultrastructural study. Ultrastruct Pathol. 1995;19(5):421–9.
Battocchio M, Zatelli MC, Chiarelli S, Trento M, Ambrosio MR, Pasquali C, et al. Ovarian tumors secreting insulin. Endocrine. 2015;49(3):611–9. doi:10.1007/s12020-015-0605-y.
Mann JR, Gray ES, Thornton C, Raafat F, Robinson K, Collins GS, et al. Mature and immature extracranial teratomas in children: The UK Children’s Cancer Study Group experience. J Clin Oncol. 2008;26(21):3590–7. doi:10.1200/jco.2008.16.0622.
Nogales FF. Unpublished observations.
Fujii K, Yamashita Y, Yamamoto T, Takahashi K, Hashimoto K, Miyata T et al. Ovarian mucinous tumors arising from mature cystic teratomas–a molecular genetic approach for understanding the cellular origin. Hum Pathol 2014;45(4):717–24. doi:10.1016/j.humpath.2013.10.031 S0046-8177(13)00478-4 [pii].
Nogales FF, Dulcey I. The secondary human yolk sac has an immunophenotype indicative of both hepatic and intestinal differentiation. Int J Dev Biol. 2012;56(9):755–760. doi:10.1387/ijdb.120080fn 120080fn [pii].
Xue D, Peng Y, Wang F, Allan RW, Cao D. RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours. Histopathology. 2011;59(3):452–9. doi:10.1111/j.1365-2559.2011.03949.x.
Preda O, Dema A, Iacob M, Goyenaga P, Dulcey I, Aneiros Fernandez J, et al. Urothelial carcinoma of the renal pelvis with simultaneous trophoblastic and malignant clear cell endodermal-type differentiation. Virchows Arch. 2012;460(3):353–6. doi:10.1007/s00428-012-1211-5.
Zynger DL, McCallum JC, Luan C, Chou PM, Yang XJ. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010;56(6):750–7. doi:10.1111/j.1365-2559.2010.03553.x HIS3553 [pii].
Preda O, Nicolae A, Aneiros-Fernandez J, Borda A, Nogales FF. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours. Histopathology 2011;58(2):312–4; author reply 4–5. doi:10.1111/j.1365-2559.2010.03735.x.
Esheba GE, Pate LL, Longacre TA. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol. 2008;32(4):600–7. doi:10.1097/PAS.0b013e31815a565a.
Pitman MB, Triratanachat S, Young RH, Oliva E. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Int J Gynecol Pathol. 2004;23(1):58–64. doi:10.1097/01.pgp.0000101141.31270.a1.
Gulluoglu MG, Karayigit E, Ozden I, Kapran Y, Dizdaroglu F. Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer? Pathology. 2008;40(1):35–41. doi:10.1080/00313020701716391.
Pelosi G, Petrella F, Sandri MT, Spaggiari L, Galetta D, Viale G. A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol. 2006;14(3):247–51. doi:14/3/247 [pii] 1177/1066896906290657.
Bing Z, Pasha T, Tomaszewski JE, Zhang P. CDX2 expression in yolk sac component of testicular germ cell tumors. Int J Surg Pathol 2009;17(5):373–7. doi:10.1177/1066896909338598 1066896909338598 [pii].
Wong HH, Chu P. Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol. 2012;3(3):262–84. doi:10.3978/j.issn.2078-6891.2012.019.
Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009;33(7):1065–77. doi:10.1097/PAS.0b013e3181a13eef.
Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33(6):894–904. doi:10.1097/PAS.0b013e318198177d.
Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009;33(10):1529–39. doi:10.1097/PAS.0b013e3181ad25d5.
Khalifa MA, Gersell DJ, Hansen CH, Lage JM. Hepatic (hepatocellular) adenoma of the placenta: a study of four cases. Int J Gynecol Pathol. 1998;17(3):241–4.
Matsuyama TA, Kushima M, Yamochi-Onizuka T, Ota H. Placental yolk sac tumor with divergent endodermal differentiation. Int J Gynecol Pathol. 2004;23(4):398–402. doi:00004347-200410000-00014 [pii].
West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009;460(7257):909–13. doi:10.1038/nature08210 nature08210 [pii].
Cao D, Allan RW, Cheng L, Peng Y, Guo CC, Dahiya N et al. RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum Pathol 2011;42(5):710–8. doi:10.1016/j.humpath.2010.09.007 S0046-8177(10)00364-3 [pii].
Cao D, Liu A, Wang F, Allan RW, Mei K, Peng Y, et al. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod Pathol. 2011;24(2):288–96. doi:10.1038/modpathol.2010.195.
Nogales FF, Dulcey I, Preda O. Issues in Gynecologic Pathology. Germ Cell Tumors of the Ovary. An Update. Arch Pathol Lab Med. 2014.
Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38(1):13–22. doi:10.1097/PAS.0b013e3182a0218f.
Schuldt M, Rubio A, Preda O, Nogales FF. GATA3 expression is present in primitive patterns of Yolk Sac Tumors but is not expressed by differentiated variants. Histopathology. 2015; doi:10.1111/his.12776.
Iacobelli JF, Charles AK, Crook M, Stewart CJ. NUT protein immunoreactivity in ovarian germ cell tumours. Pathology 2015;47(2):118–122. doi:10.1097/PAT.0000000000000208 01268031-201502000-00005 [pii].
Damato S, Haldar K, McCluggage WG. Primary endometrial yolk sac tumor with endodermal-intestinal differentiation masquerading as metastatic colorectal adenocarcinoma. Int J Gynecol Pathol. 2015; doi:10.1097/PGP.0000000000000236.
Retamero JA, Schuldt M, Nogales FF. Yolk sac tumors in postmenopausal patients arising in endometrioid adenocarcinoma. AJSP Rev Rep. 2016;21:189–94.
Ramalingam P, Malpica A, Silva EG, Gershenson DM, Liu JL, Deavers MT. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28(11):1499–505.
Nogales FF, Schuldt M, Cruz BN, Oosterhuis JW, Kaur B, Matias-Guiu X et al. Germ cell tumor growth patterns originated from clear cell carcinoma of the ovary and endometrium. Comparative immunohistochemical study proposing a putative origin from neoplastic stem cells of somatic tumors. In preparation 2017.
De Backer A, Madern GC, Pieters R, Haentjens P, Hakvoort-Cammel FG, Oosterhuis JW, et al. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors. Eur J Pediatr Surg. 2008;18(1):1–6. doi:10.1055/s-2007-989399.
Topuz S, Iyibozkurt AC, Akhan SE, Keskin N, Yavuz E, Salihoglu Y, et al. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence. Eur J Gynaecol Oncol. 2008;29(6):635–7.
Moch H, Humphrey P, Ubright TM, Reuter VE. WHO classification of tumours of the urinary system and male genital organs, World health organization classification of tumours. 4th ed. Lyon: IARC; 2016.
Hennes E, Zahn S, Lopes LF, Schonberger S, Leuschner I, Gobel U, et al. Molecular genetic analysis of bilateral ovarian germ cell tumors. Klin Padiatr. 2012;224(6):359–65. doi:10.1055/s-0032-1327606.
Kleinsmith LJ, Pierce Jr GB. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964;24:1544–51.
Malecki M, Anderson M, Beauchaine M, Seo S, Tombokan X, Malecki R. TRA-1-60, SSEA-4, Oct4A, Nanog clones of pluripotent stem cells in the embryonal carcinomas of the ovaries. J Stem Cell Res Ther. 2012;2(5) doi:130 [pii].
Cheng L, Zhang SB, Talerman A, Roth LM. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Hum Pathol. 2010;41(5):716–23. doi:10.1016/j.humpath.2009.10.016.
Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE. Hypothesis: when is a seminoma not a seminoma? J Clin Pathol. 1981;34(11):1308–9.
Kurman RJ, Norris HJ. Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer. 1976;38(6):2420–33.
Young RH, Stall JN, Sevestre H. The polyembryoma: one of the most intriguing human neoplasms, with comments on the investigator who brought it to light, Albert Peyron. Int J Gynecol Pathol. 2016;35(2):93–105. doi:10.1097/PGP.0000000000000282.
Ulbright TM, Young RH. Tumors of the tesis and adjacent structures. Atlas of tumor pathology (4th series). American Registry of Pathology: Silver Spring; 2013.
Poulos C, Cheng L, Zhang S, Gersell DJ, Ulbright TM. Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol 2006;19(6):766–71. doi:3800596 [pii] 10.1038/modpathol.3800596.
Wang D, Hu Y, He Y, Xie C, Yin R. Pure ovarian choriocarinoma mimicking ectopic pregnancy in true hermaphroditism. Acta Obstet Gynecol Scand 2009;88(7):850–2. doi:10.1080/00016340902902883 910379889 [pii].
Joneborg U, Papadogiannakis N, Lindell G, Marions L. Choriocarcinoma following ovarian hydatidiform mole: a case report. J Reprod Med. 2011;56(11–12):511–4.
Sehn JK, Kuroki LM, Hopeman MM, Longman RE, McNicholas CP, Huettner PC. Ovarian complete hydatidiform mole: case study with molecular analysis and review of the literature. Hum Pathol 2013;44(12):2861–4. doi:10.1016/j.humpath.2013.07.027 S0046-8177(13)00316-X [pii].
Gardner JK, Konner JA. Germ cell and sex cord stromal tumors: clinical introduction. In: Soslow RA, Tornos C, Eds. Diagnostic Pathology of Ovarian Tumors. New York: Springer; 2011. p. 145–53.
Cho NH, Kim YT, Lee JH, Song C, Cho SW, Cho SH, et al. Diagnostic challenge of fetal ontogeny and its application on the ovarian teratomas. Int J Gynecol Pathol. 2005;24(2):173–82. doi:00004347-200504000-00010 [pii].
Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, Munoz-Lopez M, Real PJ, Macia A, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells. 2010;28(9):1568–70. doi:10.1002/stem.471.
Doss BJ, Jacques SM, Qureshi F, Chang CH, Christensen CW, Morris RT et al. Immature teratomas of the genital tract in older women. Gynecol Oncol 1999;73(3):433–8. doi:S0090-8258(99)95345-3 [pii] 10.1006/gyno.1999.5345.
Nogales FF. Germ cell tumours of the ovary. In: Fox H, Wells M, editors. Haines & Taylor obstetrical and gynaecological pathology. 5th ed. Edinburgh: Churchill Livingstone; 2003. p. 771–820.
Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, et al. Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol. 2012;31(5):429–37. doi:10.1097/PGP.0b013e31824a1de2.
Nogales Jr FF, Favara BE, Major FJ, Silverberg SG. Immature teratoma of the ovary with a neural component (“solid” teratoma). A clinicopathologic study of 20 cases. Hum Pathol. 1976;7(6):625–42.
Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol. 1999;17(7):2137–43.
Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37(5):2359–72.
Yanai H, Matsuura H, Kawasaki M, Takada Y, Tabuchi Y, Yoshino T. Immature teratoma of the ovary with a minor rhabdomyosarcomatous component and fatal rhabdomyosarcomatous metastases: the first case in a child. Int J Gynecol Pathol. 2002;21(1):82–5.
Byun JC, Choi IJ, Han MS, Lee SC, Roh MS, Cha MS. Soft tissue metastasis of an immature teratoma of the ovary. J Obstet Gynaecol Res. 2011;37(11):1689–93. doi:10.1111/j.1447-0756.2011.01553.x.
Kurata A, Hirano K, Nagane M, Fujioka Y. Immature teratoma of the ovary with distant metastases: favorable prognosis and insights into chemotherapeutic retroconversion. Int J Gynecol Pathol. 2010;29(5):438–44. doi:10.1097/PGP.0b013e3181cef16b.
Merard R, Ganesan R, Hirschowitz L. Growing teratoma syndrome: a report of 2 cases and review of the literature. Int J Gynecol Pathol 2015;34(5):465–72. doi:10.1097/PGP.0000000000000180. 00004347-201509000-00009 [pii].
Nogales FF, Aguilar D. Florid vascular proliferation in grade 0 glial implants from ovarian immature teratoma. Int J Gynecol Pathol. 2002;21(3):305–7.
O’Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol. 1994;13(4):283–9.
King ME, Micha JP, Allen SL, Mouradian JA, Chaganti RS. Immature teratoma of the ovary with predominant malignant retinal anlage component. A parthenogenically derived tumor. Am J Surg Pathol. 1985;9(3):221–31.
Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, et al. Primary glial and neuronal tumors of the ovary or peritoneum: a clinicopathologic study of 11 cases. Am J Surg Pathol. 2016; doi:10.1097/PAS.0000000000000635.
Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 2008;32(2):219–28. doi:10.1097/PAS.0b013e318093e421 00000478-200802000-00006 [pii].
Clinkard DJ, Khalifa M, Osborned RJ, Bouffet E. Successful management of medulloblastoma arising in an immature ovarian teratoma in pregnancy. Gynecol Oncol 2011;120(2):311–2. doi:10.1016/j.ygyno.2010.10.022 S0090-8258(10)00768-7 [pii].
Morency EG, Lerner D, Garcia R, Kalir T. High-grade sarcoma masquerading as growing teratoma syndrome after resection of ovarian immature teratoma: report of a case. Int J Gynecol Pathol. 2012;31(3):276–9. doi:10.1097/PGP.0b013e31823ef912.
Malagon HD, Valdez AM, Moran CA, Suster S. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases. Am J Surg Pathol 2007;31(9):1356–62. doi:10.1097/PAS.0b013e318033c7c4 00000478-200709000-00008 [pii].
Mengshol SC, Demars LR, Schned AR. Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst. Gynecol Oncol. 2004;92(1):353–6.
DiSaia PJ, Saltz A, Kagan AR, Morrow CP. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol. 1977;49(3):346–50.
Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer. 1982;50(8):1629–35.
Kato N, Uchigasaki S, Fukase M. How does secondary neoplasm arise from mature teratomas in growing teratoma syndrome of the ovary? A report of two cases. Pathol Int. 2013;63(12):607–10. doi:10.1111/pin.12112.
Djordjevic B, Euscher ED, Malpica A. Growing teratoma syndrome of the ovary: review of literature and first report of a carcinoid tumor arising in a growing teratoma of the ovary. Am J Surg Pathol 2007;31(12):1913–8. doi:10.1097/PAS.0b013e318073cf44 00000478-200712000-00017 [pii].
Nogales FF, Preda O, Dulcey I. Gliomatosis peritonei as a natural experiment in tissue differentiation. Int J Dev Biol 2012;56(10–12):969–74. doi:10.1387/ijdb.120172fn 120172fn [pii].
Wu XH, Han LY, Xu X, Li ZT. Recurrent immature teratoma of the ovary: a case report of radical secondary cytoreduction with replacement of the aortic bifurcation. Gynecol Oncol. 2004;95(3):746–9. doi:10.1016/j.ygyno.2004.08.007.
Yoon NR, Lee JW, Kim BG, Bae DS, Sohn I, Sung CO, et al. Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma. Virchows Arch. 2012;461(3):299–304. doi:10.1007/s00428-012-1285-0.
Gonzalez-Campora R, Nogales Jr FF, Davidson HG, Mendez JA. Case report: ultrastructure of mature neurogenic implants from ovarian immature teratoma. Histopathology. 1979;3(3):233–40.
Webman R, Talishinskiy T, Raetz E, Lala S, Tomita S. Spontaneous regression of thoracic and extraperitoneal glial implants in child with gliomatosis peritonei after resection of ovarian teratoma. J Pediatr Hematol Oncol. 2014; doi:10.1097/MPH.0000000000000230.
Webman R, Talishinskiy T, Raetz E, Lala S, Tomita S. Spontaneous regression of thoracic and extraperitoneal glial implants in child with gliomatosis peritonei after resection of ovarian teratoma. J Pediatr Hematol Oncol. 2015;37(3):230–1. doi:10.1097/MPH.0000000000000230.
Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, et al. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015;28(12):1613–20. doi:10.1038/modpathol.2015.116.
Kim NR, Lim S, Jeong J, Cho HY. Peritoneal and nodal gliomatosis with endometriosis, accompanied with ovarian immature teratoma: a case study and literature review. Korean J Pathol. 2013;47(6):587–91. doi:10.4132/KoreanJPathol.2013.47.6.587.
Lobotesis K, U-King-Im JM, Cross JJ, Gillard JH, Antoun NM. Gliomatosis peritonei associated with a ventriculo-peritoneal shunt. Clin Radiol 2009;64(1):95–9. doi:10.1016/j.crad.2008.08.015 S0009-9260(08)00374-7 [pii].
Ferguson AW, Katabuchi H, Ronnett BM, Cho KR. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol. 2001;159(1):51–5. doi:10.1016/s0002-9440(10)61672-0.
Kwan MY, Kalle W, Lau GT, Chan JK. Is gliomatosis peritonei derived from the associated ovarian teratoma? Hum Pathol. 2004;35(6):685–8. doi:S004681770400108X [pii].
Alexander M, Cope N, Renninson J, Hong A, Simpson RH, Hirschowitz L. Relationship between endometriosis, endometrioid adenocarcinoma, gliomatosis peritonei, and carcinoid tumor in a patient with recurrent ovarian teratoma. Int J Gynecol Pathol. 2011;30(2):151–7. doi:10.1097/PGP.0b013e3181f6bcd4.
Abiko K, Mandai M, Hamanishi J, Matsumura N, Baba T, Horiuchi A et al. Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation. Am J Surg Pathol 2010;34(12):1842–8. doi:10.1097/PAS.0b013e3181fcd707 00000478-201012000-00012 [pii].
Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med. 1975;292(2):63–6. doi:10.1056/NEJM197501092920202.
Dahl N, Gustavson KH, Rune C, Gustavsson I, Pettersson U. Benign ovarian teratomas. An analysis of their cellular origin. Cancer Genet Cytogenet. 1990;46(1):115–23.
Besser MJ, Posey DM. Cystic teratoma in a supernumerary ovary of the greater omentum. A case report. J Reprod Med. 1992;37(2):189–93.
Nezhat C, Kotikela S, Mann A, Hajhosseini B, Veeraswamy A, Lewis M. Familial cystic teratomas: four case reports and review of the literature. J Minim Invasive Gynecol 2010;17(6):782–6. doi:10.1016/j.jmig.2010.06.006 S1553-4650(10)00333-X [pii].
Brown Jr EH. Identical twins with twisted benign cystic teratoma of the ovary. Am J Obstet Gynecol. 1979;134(8):879–80. doi:0002-9378(79)90860-3 [pii].
Saba L, Guerriero S, Sulcis R, Virgilio B, Melis G, Mallarini G. Mature and immature ovarian teratomas: CT, US and MR imaging characteristics. Eur J Radiol 2009;72(3):454–63. doi:10.1016/j.ejrad.2008.07.044 S0720-048X(08)00457-9 [pii].
Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25–36. doi:10.1002/ana.21050.
Dalmau J, Rosenfeld MR. Update on paraneoplastic neurologic disorders. Commun Oncol. 2010;7(5):219–24.
Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594–604. doi:10.1002/ana.20614.
Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res 2014. doi:S0920-9964(14)00546-5 [pii] 10.1016/j.schres.2014.10.007.
Dulcey I, Cespedes MU, Ballesteros JL, Preda O, Aneiros-Fernandez J, Clavero PA et al. Necrotic mature ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis. Pathol Res Pract 2012;208(8):497–500. doi:10.1016/j.prp.2012.05.018 S0344-0338(12)00156-2 [pii].
Templeman CL, Fallat ME, Lam AM, Perlman SE, Hertweck SP, O’Connor DM. Managing mature cystic teratomas of the ovary. Obstet Gynecol Surv. 2000;55(12):738–45.
Kim MJ, Kim NY, Lee DY, Yoon BK, Choi D. Clinical characteristics of ovarian teratoma: age-focused retrospective analysis of 580 cases. Am J Obstet Gynecol. 2011;205(1):32 e1–4. doi:10.1016/j.ajog.2011.02.044 S0002-9378(11)00234-1 [pii].
Peitsidou A, Peitsidis P, Goumalatsos N, Papaspyrou R, Mitropoulou G, Georgoulias N. Diagnosis of an autoamputated ovary with dermoid cyst during a Cesarean section. Fertil Steril. 2009;91(4):1294 e9–12. doi:10.1016/j.fertnstert.2008.12.029 S0015-0282(08)04725-0 [pii].
Kusaka M, Mikuni M. Ectopic ovary: a case of autoamputated ovary with mature cystic teratoma into the cul-de-sac. J Obstet Gynaecol Res. 2007;33(3):368–70. doi:JOG538 [pii] 10.1111/j.1447-0756.2007.00538.x.
Siegel MJ, McAlister WH, Shackelford GD. Radiographic findings in ovarian teratomas in children. AJR Am J Roentgenol. 1978;131(4):613–5. doi:10.2214/ajr.131.4.613.
Shetty NS, Vallabhaneni S, Patil A, Babu MM, Baig A. Unreported location and presentation for a parasitic ovarian dermoid cyst in an indirect inguinal hernia. Hernia. 2013;17(2):263–5. doi:10.1007/s10029-011-0876-z.
Sinha R, Sundaram M, Lakhotia S. Multiple intraabdominal parasitic cystic teratomas. J Minim Invasive Gynecol 2009;16(6):789–91. doi:10.1016/j.jmig.2009.08.003 S1553-4650(09)00443-9 [pii].
Takeda A, Imoto S, Mori M, Yamada J, Nakamura H. Early abdominal pregnancy complicated by parasitic dermoid cyst: diagnosis by diffusion-weighted magnetic resonance imaging and management by laparoendoscopic single-site surgery. J Minim Invasive Gynecol 2012;19(5):647–50. doi:10.1016/j.jmig.2012.03.024 S1553-4650(12)00127-6 [pii].
Cucinella G, Granese R, Venezia R, Mangione D, Calagna G, Perino A. Parasitic dermoid cyst coexisting with absence of an adnexa. Acta Obstet Gynecol Scand. 2011;90(6):677–8. doi:10.1111/j.1600-0412.2011.01125.x.
Walid MS, Boddy MG. Bilateral dermoid cysts of the ovary in a pregnant woman: case report and review of the literature. Arch Gynecol Obstet. 2009;279(2):105–8. doi:10.1007/s00404-008-0695-3.
Feltingoff M, Heller DS, Bleiweiss IJ. Ovarian pregnancy with ipsilateral mature cystic teratoma of the ovary: case report. Mt Sinai J Med. 1992;59(1):82–4.
Nogales FF, Fernandez-Sanz J, Fulwood H, Matilla A, Galera-Davidson H. Estudio clínico-patológico de 288 teratomas quísticos de ovario. Patologia (Madrid). 1979;16:12–25.
Goh W, Bohrer J, Zalud I. Management of the adnexal mass in pregnancy. Curr Opin Obstet Gynecol 2014;26(2):49–53. doi:10.1097/GCO.0000000000000048 00001703-201404000-00002 [pii].
Tariel O, Huissoud C, Rudigoz RC, Dubernard G. [Presumed benign ovarian tumors during pregnancy]. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):842–55. doi:10.1016/j.jgyn.2013.09.038 S0368-2315(13)00284-6 [pii].
Erdemoglu M, Kuyumcuoglu U, Kale A. Pregnancy and adnexal torsion: analysis of 20 cases. Clin Exp Obstet Gynecol. 2010;37(3):224–5.
Ulstein M, Rana G, Yangzom K, Gurung R. Prolapse of an ovarian tumor during labor. Acta Obstet Gynecol Scand. 1987;66(8):721–2.
Nader R, Thubert T, Deffieux X, de Laveaucoupet J, Ssi-Yan-Kai G. Delivery induced intraperitoneal rupture of a cystic ovarian teratoma and associated chronic chemical peritonitis. Case Rep Radiol. 2014;2014:189409. doi:10.1155/2014/189409.
Yoshikata R, Yamamoto T, Kobayashi M, Ota H. Immunohistochemical characteristics of mature ovarian cystic teratomas in patients with postoperative recurrence. Int J Gynecol Pathol. 2006;25(1):95–100. doi:00004347-200601000-00014 [pii].
Anteby EY, Ron M, Revel A, Shimonovitz S, Ariel I, Hurwitz A. Germ cell tumors of the ovary arising after dermoid cyst resection: a long-term follow-up study. Obstet Gynecol. 1994;83(4):605–8.
Chapron C, Dubuisson JB, Samouh N, Foulot H, Aubriot FX, Amsquer Y, et al. Treatment of ovarian dermoid cysts. Place and modalities of operative laparoscopy. Surg Endosc. 1994;8(9):1092–5.
Arora DS, Haldane S. Carcinosarcoma arising in a dermoid cyst of the ovary. J Clin Pathol. 1996;49(6):519–21.
Amerigo J, Nogales Jr FF, Fernandez-Sanz J, Oliva H, Velasco A. Squamous cell neoplasms arising from ovarian benign cystic teratoma. Gynecol Oncol. 1979;8(3):277–83.
Pansky M, Shade D, Moskovitch M, Halperin R, Ben-Ami I, Smorgick N. Inadvertent rupture of benign cystic teratoma does not impair future fertility. Am J Obstet Gynecol. 2010;203(5):442 e1–4. doi:10.1016/j.ajog.2010.06.062 S0002-9378(10)00842-2 [pii].
Pantoja E, Noy MA, Axtmayer RW, Colon FE, Pelegrina I. Ovarian dermoids and their complications. Comprehensive historical review. Obstet Gynecol Surv. 1975;30(1):1–20.
Stuart GC, Smith JP. Ruptured benign cystic teratomas mimicking gynecologic malignancy. Gynecol Oncol. 1983;16(1):139–43.
Gendre J, Sebban-Rozot C, Regent D, Ranchoup Y, Ridereau-Zins C, Vullierme MP et al. [Peritoneal parasitic teratoma and chemical dermoid peritonitis]. J Radiol 2011;92(5):382–92. doi:10.1016/j.jradio.2011.03.005 S0221-0363(11)00117-X [pii].
Maiti S, Fatima Z, Anjum ZK, Hopkins RE. Ruptured ovarian cystic teratoma in pregnancy with diffuse peritoneal reaction mimicking advanced ovarian malignancy: a case report. J Med Case Rep 2008;2:203. doi:10.1186/1752-1947-2-203 1752-1947-2-203 [pii].
Sasaki H, Nagasako K, Harada M, Kobayashi S, Uetake K. Benign cystic teratoma of the ovary with rupture into the rectum: report of a unique rectal tumor. Dis Colon Rectum. 1979;22(4):248–51.
Suzuki M, Fukasawa M, Hara T. Dermoid cyst with thyroid follicle perforated into bladder and ileum: a case report. Nihon Hinyokika Gakkai Zasshi. 1999;90(5):586–9.
von-Walter AR, Nelken RS. Benign cystic ovarian teratoma with a fistula into the small and large bowel. Obstet Gynecol 2012;119(2 Pt 2):434–6. doi:10.1097/AOG.0b013e3182319185 00006250-201202001-00007 [pii].
Sardesai S, Raghoji V, Dabade R, Shaikh H. Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case. J Obstet Gynaecol India 2012;62(Suppl 1):54–5. doi:10.1007/s13224-013-0354-x 354 [pii].
Candela G, Di Libero L, Varriale S, Manetta F, Napolitano S, Scetta G, et al. Hemoperitoneum caused by the rupture of a giant ovarian teratoma in a 9-year-old female. Case report and literature review. Ann Ital Chir. 2009;80(2):141–4.
Fukushima M, Sharpe L, Okagaki T. Peritoneal melanosis secondary to a benign dermoid cyst of the ovary: a case report with ultrastructural study. Int J Gynecol Pathol. 1984;2(4):403–9.
Jaworski RC, Boadle R, Greg J, Cocks P. Peritoneal “melanosis” associated with a ruptured ovarian dermoid cyst: report of a case with electron-probe energy dispersive X-ray analysis. Int J Gynecol Pathol. 2001;20(4):386–9.
Brelje MC, Garcia-Bunuel R. Salmonella infection in an ovarian dermoid cyst in pregnancy: report of a case. Obstet Gynecol. 1964;24:279–80.
Matsubayashi T, Hamajima T, Asano K, Mizukami A, Seguchi M, Kohno C, et al. Salmonella infection of an ovarian dermoid cyst. Pediatr Int. 2001;43(2):164–5. doi:ped1351 [pii].
Salehpour S, Akbari Sene A. Super infection of an ovarian dermoid cyst with actinomyces in an infertile woman. Int J Fertil Steril. 2013;7(2):134–7.
Melato M, Muuse MM, Hussein AM, Falconieri G. Schistosomiasis in a cystic teratoma of the ovary. Clin Exp Obstet Gynecol. 1987;14(1):57–9.
Sane SY, Patel CV. A filarial worm in the wall of a cystic teratoma of the ovary–(a case report). J Postgrad Med. 1989;35(4):217–8.
Cobo F, Pereira A, Nomdedeu B, Gallart T, Ordi J, Torne A, et al. Ovarian dermoid cyst-associated autoimmune hemolytic anemia: a case report with emphasis on pathogenic mechanisms. Am J Clin Pathol. 1996;105(5):567–71.
Payne D, Muss HB, Homesley HD, Jobson VW, Baird FG. Autoimmune hemolytic anemia and ovarian dermoid cysts: case report and review of the literature. Cancer. 1981;48(3):721–4.
Ibarra M, Chou P, Pachman LM. Ovarian teratoma mimicking features of juvenile dermatomyositis in a child. Pediatrics 2011;128(5):e1293–6. doi:10.1542/peds.2010-2115 peds.2010-2115 [pii].
Wiese W, Alansari H, Tranchida P, Madrid FF. Paraneoplastic polyarthritis in an ovarian teratoma. J Rheumatol. 2004;31(9):1854–7. doi:0315162X-31-1854 [pii].
Deen R, de Silva A, Wijesuriya R. Twisted benign ovarian teratoma presenting with pain and generalized pruritus: a case report. J Med Case Rep 2013;7(1):130. doi:10.1186/1752-1947-7-130 1752-1947-7-130 [pii].
Di Stefano F, Siriruttanapruk S, Di Gioacchino M. Exercise-induced urticarial vasculitis as a paraneoplastic manifestation of cystic teratoma. Rheumatology (Oxford). 2003;42(11):1418–9. doi:10.1093/rheumatology/keg346 42/11/1418 [pii].
Frawley KJ, Calvo-Garcia MA, Krueger DA, McMasters RL. ‘Benign’ ovarian teratoma and N-methyl-D-aspartate receptor (NMDAR) encephalitis in a child. Pediatr Radiol. 2012;42(1):120–3. doi:10.1007/s00247-011-2111-6.
McCarthy A, Dineen J, McKenna P, Keogan M, Sheehan J, Lynch T, et al. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. J Neurol. 2012;259(12):2632–5. doi:10.1007/s00415-012-6561-z.
Lupi I, Fessehatsion R, Manca A, Cossu-Rocca P, Martino E, Macchia E. Hashimoto’s thyroiditis in a benign cystic teratoma of the ovary: case report and literature review. Gynecol Endocrinol. 2012;28(1):39–42. doi:10.3109/09513590.2011.579659.
Amareen VN, Haddad FH, Al-Kaisi NS. Hypothyroidism due to Hashimoto thyroiditis post struma ovarii excision. Saudi Med J. 2004;25(7):948–50. doi:20030587’ [pii].
Elms AF, Carlan SJ, Rich AE, Cerezo L. Ovarian tumor-derived ectopic hyperprolactinemia. Pituitary. 2012;15(4):552–5. doi:10.1007/s11102-011-0366-4.
Klonoff DC, Kahn DG, Rosenzweig W, Wilson CB. Hyperprolactinemia in a patient with a pituitary and an ovarian dermoid tumor: case report. Neurosurgery. 1990;26(2):335–9.
Takeuchi K, Murata K, Funaki K, Kitazawa S, Kitazawa R. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy. Gynecol Oncol 2000;79(3):504–7. doi:10.1006/gyno.2000.5945 S0090-8258(00)95945-6 [pii].
Gunasekaran S, Kopecka E, Maung KH, England RJ. Struma ovarii and the thyroid surgeon. J Laryngol Otol 2012;126(8):858–60. doi:10.1017/S0022215112000904 S0022215112000904 [pii].
Deffieux X, Thubert T, Huchon C, Demoulin G, Rivain AL, Faivre E et al. [Complications of presumed benign ovarian tumors]. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):816–32. doi:10.1016/j.jgyn.2013.09.036 S0368-2315(13)00282-2 [pii].
Axiotis CA, Lippes HA, Merino MJ, deLanerolle NC, Stewart AF, Kinder B. Corticotroph cell pituitary adenoma within an ovarian teratoma. A new cause of Cushing’s syndrome. Am J Surg Pathol. 1987;11(3):218–24.
Tsujimoto T, Takaichi M, Endo H, Yasuda K, Kishimoto M, Noto H, et al. A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a Brenner tumor. e. 2011;341(1):74–7. doi:10.1097/MAJ.0b013e3181f54e59.
Hoffman JG, Strickland JL, Yin J. Virilizing ovarian dermoid cyst with leydig cells. J Pediatr Adolesc Gynecol 2009;22(3):e39–40. doi:10.1016/j.jpag.2008.05.012 S1083-3188(08)00194-0 [pii].
Lopez-Beltran A, Calanas AS, Jimena P, Escudero AL, Campello TR, Munoz-Torres M, et al. Virilizing mature ovarian cystic teratomas. Virchows Arch. 1997;431(2):149–51.
Rutgers JL, Scully RE. Functioning ovarian tumors with peripheral steroid cell proliferation: a report of twenty-four cases. Int J Gynecol Pathol. 1986;5(4):319–37.
Robboy SJ, Scully RE. Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980;46(9):2019–34.
Ober WB. Solid ovarian teratoma with struma ovarii, theca lutein reaction, and endometrial hyperplasia. Report of a case. J Obstet Gynaecol Br Emp. 1960;67:451–4.
Murdoch W, Sadoski J, Rosin FC. Multisystem manifestations of benign ovarian teratomas. J Am Board Fam Med. 2014;27(3):421–3. doi:10.3122/jabfm.2014.03.130221 27/3/421 [pii].
Sahin AA, Ro JY, Chen J, Ayala AG. Spindle cell nodule and peptic ulcer arising in a fully developed gastric wall in a mature cystic teratoma. Arch Pathol Lab Med. 1990;114(5):529–31.
Tiltman AJ, Glass DR, Duffield MS. Peptic ulceration in a mature cystic teratoma of the ovary. Histopathology. 1995;26(4):375–7.
Kirova YM, Feuilhade F, de Baecque-Fontaine C, Le Bourgeois JP. Metastasis of a breast carcinoma in a mature teratoma of the ovary. Eur J Gynaecol Oncol. 1999;20(3):223–5.
Damewood M, Rosenshein NB, Woodruff JD. Multiple benign cystic teratomas of the ovary. Report of two cases and review of the literature. Diagn Gynecol Obstet. 1982;4(3):243–5.
Monk BE, Isaacs AJ, Bayliss R. Giant ovarian dermoid masked by obesity. Postgrad Med J. 1980;56(660):748–9.
Canda AE, Astarcioglu H, Obuz F, Canda MS. Cystic ovarian teratoma with intracystic floating globules. Abdom Imaging. 2005;30(3):369–71. doi:10.1007/s00261-004-0266-4.
Devoize L, Collangettes D, Le Bouedec G, Mishellany F, Orliaguet T, Dallel R et al. Giant mature ovarian cystic teratoma including more than 300 teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(3):e76–9. doi:10.1016/j.tripleo.2007.10.001 S1079-2104(07)00819-0 [pii].
Chavan SS, Yenni VV. Mandible like structure with fourteen teeth in a benign cystic teratoma. Indian J Pathol Microbiol. 2009;52(4):595–6. doi:10.4103/0377-4929.56145 IndianJPatholMicrobiol_2009_52_4_595_56145 [pii].
Ingale Y, Shankar AA, Routray S, Agrawal M, Kadam A, Patil T. Ectopic teeth in ovarian teratoma: a rare appearance. Case Rep Dent. 2013;2013:970464. doi:10.1155/2013/970464.
Willis RA. The spread of tumours in the human body. 3rd ed. London: Butterworths; 1973.
Kuno N, Kadomatsu K, Nakamura M, Miwa-Fukuchi T, Hirabayashi N, Ishizuka T. Mature ovarian cystic teratoma with a highly differentiated homunculus: a case report. Birth Defects Res A Clin Mol Teratol. 2004;70(1):40–6. doi:10.1002/bdra.10133.
Abbott TM, Hermann Jr WJ, Scully RE. Ovarian fetiform teratoma (homunculus) in a 9-year-old girl. Int J Gynecol Pathol. 1984;2(4):392–402.
Joutel N, Pirot N, Pop I, Khoutech K, Bisson V, Cingotti M et al. Homunculus: fetiform teratoma. Gynecol Obstet Fertil 2012;40(2):121–3. doi:10.1016/j.gyobfe.2011.07.046 S1297-9589(11)00273-6 [pii].
Weldon-Linne CM, Rushovich AM. Benign ovarian cystic teratomas with homunculi. Obstet Gynecol. 1983;61(3 Suppl):88S–94S.
Di Donato N, Zanello M, Corti B, Seracchioli R, Paradisi R. Incidental diagnosis of ectopic adenohypophyseal tissue in an ovarian dermoid cyst: a case report. Eur J Obstet Gynecol Reprod Biol. 2014;183:203–4. doi:10.1016/j.ejogrb.2014.10.044. S0301-2115(14)00568-5 [pii].
McKeel Jr DW, Askin FB. Ectopic hypophyseal hormonal cells in benign cystic teratoma of the ovary. Light microscopic histochemical dye staining and immunoperoxidase cytochemistry. Arch Pathol Lab Med. 1978;102(3):122–8.
Khan N, Sen Ray P, Hakim S, Ziyauddin F. Retinal tissue in mature cystic teratoma of ovary presenting with full-term pregnancy. BMJ Case Rep. 2014;2014. doi:10.1136/bcr-2013-202914. bcr2013202914 [pii] bcr-2013-202914 [pii].
Mercur L, Farkas TG, Anker PM, Brill R, Mund ML. Developing eye in an ovarian teratoma. Arch Ophthalmol. 1976;94(4):597–8.
Oi RH, Dobbs M. Lactating breast tissue in benign cystic teratoma. Am J Obstet Gynecol. 1978;130(6):729–31. doi:0002-9378(78)90342-3 [pii].
Ulirsch RC, Goldman RL. An unusual teratoma of the ovary: neurogenic cyst with lactating breast tissue. Obstet Gynecol. 1982;60(3):400–2.
Muretto P. The relationship of Langerhans cells to melanocytes and Schwann cells in mature cystic teratomas of the ovary. Int J Surg Pathol. 2007;15(3):266–71. doi:15/3/266 [pii] 10.1177/1066896907302227.
Nogales Jr FF, Ortega I, Rivera F, Armas JR. Metanephrogenic tissue in immature ovarian teratoma. Am J Surg Pathol. 1980;4(3):297–9.
Lopez JI, de Santamaria IS, Claros IJ, Garmendia M, Gaafar A, Bilbao FJ. Prostatic remnants in mature cystic teratoma of the ovary. Ann Diagn Pathol 2008;12(5):378–80. doi:10.1016/j.anndiagpath.2007.04.005 S1092-9134(07)00054-8 [pii].
Nogales FF, Vergara E, Medina MT. Prostate in ovarian mature cystic teratoma. Histopathology. 1995;26(4):373–5.
Melniker LA, Slavutin LJ. Prostatic tissue in a benign cystic teratoma of the ovary. Diagn Gynecol Obstet. 1980;2(2):139–45.
Shelekhova KV, Hejda V, Kazakov DV, Michal M. Mature cystic teratoma of the ovary with male accessory sexual glands including seminal vesicles, prostatic tissue, and bulbo-urethral glands: a case report. Virchows Arch. 2008;452(1):109–11. doi:10.1007/s00428-007-0546-9.
Glavina-Durdov M, Forempoher G. Thymus tissue in ovarian cystic teratoma: possible clues to its histogenesis. Pathol Res Pract 2000;196(11):795–7; discussion 8–9. doi:S0344-0338(00)80116-8 [pii] 10.1016/S0344-0338(00)80116-8.
Agarwal K, Agarwal C, Agarwal S, Chaddha R. Mature teratoma with loops of colon: a case report. Indian J Pathol Microbiol. 2007;50(2):405–7.
Woodfield B, Katz DA, Cantrell CJ, Bogard PJ. A benign cystic teratoma with gastrointestinal tract development. Am J Clin Pathol. 1985;83(2):236–40.
Zaragoza Vargas PE, Dickter S, Baquera Heredia J, Ortiz Hidalgo C. Gastric wall in benign cystic teratoma of the ovary. Ginecol Obstet Mex. 2007;75(1):43–5.
Agaimy A, Lindner M, Wuensch PH. Interstitial cells of Cajal (ICC) in mature cystic teratoma of the ovary. Histopathology 2006;48(2):208–9. doi:HIS2211 [pii] 10.1111/j.1365-2559.2005.02211.x.
Agaimy A, Wunsch PH. Coexistence of interstitial cell of Cajal hyperplasia and microcarcinoidosis in a mature cystic teratoma of the ovary. Histopathology 2008;52(2):260–2. doi:HIS2910 [pii] 10.1111/j.1365-2559.2007.02910.x.
Marucci G, Collina G. Mature cystic teratoma of the ovary with a small ganglioneuroma. Pathologica. 2006;98(1):41–3.
Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Well-differentiated cerebellum within a mature cystic teratoma of the ovary. Int J Clin Exp Pathol. 2014;7(3):1255–7.
Dominguez-Rosado I, Michel J, Ortiz-Hidalgo C. Ovarian mature cystic teratoma exhibiting well-differentiated cerebellum in a 14-year-old female. Pediatr Dev Pathol. 2005;8(2):247–9. doi:10.1007/s10024-004-7083-1.
MacSween RN. Foetal cerebellar tissue in an ovarian teratoma. J Pathol Bacteriol. 1968;96(2):513–4. doi:10.1002/path.1700960235.
Nogales FF, Aguilar D. Neural tissue in human teratomas. In:The biology of teratomas. Clifton: Human Press; 1983.
PN V. Spontaneous myospherulosis developing at contact with a mature cystic dysembryoma of the ovary. Pathogenetic discussion apropos of a case diagnosed by laparoscopic biopsy. J Gynecol Obstet Biol Reprod (Paris). 1988;17(1):15–8.
Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis. Am J Surg Pathol. 1989;13(5):397–405.
McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol. 2008;32(5):645–55. doi:10.1097/PAS.0b013e31815b486d.
Choi EJ, Koo YJ, Jeon JH, Kim TJ, Lee KH, Lim KT. Clinical experience in ovarian squamous cell carcinoma arising from mature cystic teratoma: A rare entity. Obstet Gynecol Sci. 2014;57(4):274–80. doi:10.5468/ogs.2014.57.4.274.
Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Eur J Obstet Gynecol Reprod Biol 2008;141(2):173–8. doi:10.1016/j.ejogrb.2008.07.032 S0301-2115(08)00298-4 [pii].
Park JY, Song JS, Choi G, Kim JH, Nam JH. Pure primary squamous cell carcinoma of the ovary: a report of two cases and review of the literature. Int J Gynecol Pathol 2010;29(4):328–34. doi:10.1097/PGP.0b013e3181c6d965 00004347-201007000-00005 [pii].
Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 2007;31(6):854–69. doi:10.1097/PAS.0b013e31802efb45 00000478-200706000-00005 [pii].
Quinonez E, Schuldt M, Retamero JA, Nogales FF. Ovarian strumal carcinoid containing appendiceal-type mucinous tumor patterns presenting as pseudomyxoma peritonei. Int J Gynecol Pathol. 2015;34(3):293–7. doi:10.1097/PGP.0000000000000138.
Nakatsuka S, Wakimoto T, Ozaki K, Nagano T, Kimura H, Nakajo K, et al. Mucinous borderline-like tumor of the gastrointestinal type arising from mature cystic teratoma of the ovary and its immunohistochemical cytokeratin and mucin phenotype. J Obstet Gynaecol Res. 2012;38(2):471–5. doi:10.1111/j.1447-0756.2011.01729.x.
McCluggage WG, Bissonnette JP, Young RH. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms. Int J Gynecol Pathol 2006;25(4):321–9. doi:10.1097/01.pgp.0000215301.39900.07 00004347-200610000-00002 [pii].
Hurwitz JL, Fenton A, McCluggage WG, McKenna S. Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series. BJOG 2007;114(10):1283–7. doi:BJO1478 [pii] 10.1111/j.1471-0528.2007.01478.x.
Pantoja E, Rodriguez-Ibanez I, Axtmayer RW, Noy MA, Pelegrina I. Complications of dermoid tumors of the ovary. Obstet Gynecol. 1975;45(1):89–94.
Marcial-Rojas RA, Medina R. Cystic teratomas of the ovary; a clinical and pathological analysis of two hundred sixty-eight tumors. AMA Arch Pathol. 1958;66(4):577–89.
Klionsky BL, Nickens OJ, Amortegui AJ. Squamous cell carcinoma in situ arising in adult cystic teratoma of the ovary. Arch Pathol. 1972;93(2):161–3.
Nogales FF, Luna MA, Vergara E, O’Valle F, Lopez-Cantarero M. Small-cell epidermoid carcinoma with melanocyte colonization arising in a mature ovarian cystic teratoma. Arch Pathol Lab Med. 1995;119(6):551–4.
Karateke A, Gurbuz A, Kir G, Haliloglu B, Kabaca C, Devranoglu B et al. Mucoepidermoid variant of adenosquamous carcinoma arising in ovarian dermoid cyst: a case report and review of the literature. Int J Gynecol Cancer 2006;16 Suppl 1:379–84. doi:IJG233 [pii] 10.1111/j.1525-1438.2006.00233.x.
Iwasa A, Oda Y, Kaneki E, Ohishi Y, Kurihara S, Yamada T et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: an immunohistochemical analysis of its tumorigenesis. Histopathology 2007;51(1):98–104. doi:HIS2727 [pii] 10.1111/j.1365-2559.2007.02727.x.
Fox H. Bronchial carcinoma in an ovarian cystic teratoma (dermoid). J Clin Pathol. 1965;18:164–6.
Yahata T, Kawasaki T, Serikawa T, Suzuki M, Tanaka K. Adenocarcinoma arising from respiratory ciliated epithelium in benign cystic teratoma of the ovary: a case report with analyzes of the CT, MRI, and pathological findings. J Obstet Gynaecol Res. 2008;34(3):408–12. doi:10.1111/j.1447-0756.2008.00784.x JOG784 [pii].
Hershkovitz D, Vlodavsky E, Simon E, Ben-Izhak O. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: Case report and review of literature. Pathol Int. 2013;63(12):611–4. doi:10.1111/pin.12123.
Fujiwara K, Ginzan S, Silverberg SG. Mature cystic teratomas of the ovary with intestinal wall structures harboring intestinal- type epithelial neoplasms. Gynecol Oncol 1995;56(1):97–101. doi:S0090-8258(85)71017-7 [pii] 10.1006/gyno.1995.1017.
Clark ME, Will MD. Intestinal-type adenocarcinoma arising in a mature cystic teratoma of the ovary. Int J Gynecol Pathol. 2016; doi:10.1097/PGP.0000000000000258.
Halabi M, Oliva E, Mazal PR, Breitenecker G, Young RH. Prostatic tissue in mature cystic teratomas of the ovary: a report of four cases, including one with features of prostatic adenocarcinoma, and cytogenetic studies. Int J Gynecol Pathol. 2002;21(3):261–7.
Stanhiser J, Mahdi H, Rosa G, Harper H, Shepard D, Rose PG, et al. Prostate-type adenocarcinoma in mature cystic ovarian teratoma. Int J Gynecol Pathol. 2016;35(2):185–90. doi:10.1097/PGP.0000000000000217.
Wheeler L, Westhoff GL, O’Keefe MC, Kong CS, Karam A. Adenocarcinoma with breast/adnexal and upper gastrointestinal differentiation arising in an ovarian mature cystic teratoma: a case report and review of the literature. Int J Gynecol Pathol. 2016;35(1):72–7. doi:10.1097/PGP.0000000000000218.
Monteagudo C, Torres JV, Llombart-Bosch A. Extramammary Paget’s disease arising in a mature cystic teratoma of the ovary. Histopathology. 1999;35(6):582–4. doi:his833d [pii].
Shimizu S, Kobayashi H, Suchi T, Torii Y, Narita K, Aoki S. Extramammary Paget’s disease arising in mature cystic teratoma of the ovary. Am J Surg Pathol. 1991;15(10):1002–6.
Randall BJ, Ritchie C, Hutchison RS. Paget’s disease and invasive undifferentiated carcinoma occurring in a mature cystic teratoma of the ovary. Histopathology. 1991;18(5):469–70.
Shintaku M, Nakagawa E, Tsubura A. Extramammary Paget’s disease arising in a mature cystic teratoma of the ovary: immunohistochemical expression of androgen receptor. Pathol Int. 2011;61(8):498–500. doi:10.1111/j.1440-1827.2011.02692.x.
Hyun HS, Mun ST. Primary malignant melanoma arising in a cystic teratoma. Obstet Gynecol Sci. 2013;56(3):201–4. doi:10.5468/ogs.2013.56.3.201.
Lee J, Magpayo J, Panchari C, Peng SK. Primary malignant melanoma of the ovary arising in a cystic teratoma; case report and review of the literature. Dermatol Online J. 2014;20(10). doi:13030/qt0tr2b2z9 [pii].
Godoy HE, Kesterson JP, Kasznica JM, Lele S. Malignant melanoma arising in mature cystic teratoma of the ovary. Gynecol Oncol Case Rep 2011;2(1):14–5. doi:10.1016/j.gynor.2011.10.007 S2211-338X(11)00016-0 [pii].
Boughton RS, Hughmanick S, Marin-Padilla M. Malignant melanoma arising in an ovarian cystic teratoma in pregnancy. J Am Acad Dermatol. 1987;17(5 Pt 2):871–5.
Mathios AJ, McCausland AM. Basal cell carcinoma originating in a benign cystic teratoma of the ovary. Obstet Gynecol. 1973;42(6):892–6.
Alfsen GC, Strom EH. Pilomatrixoma of the ovary: a rare variant of mature teratoma. Histopathology. 1998;32(2):182–3.
An HJ, Jung YH, Yoon HK, Jung SJ. Sebaceous carcinoma arising in mature cystic teratoma of ovary. Korean J Pathol. 2013;47(4):383–7. doi:10.4132/KoreanJPathol.2013.47.4.383.
Chumas JC, Scully RE. Sebaceous tumors arising in ovarian dermoid cysts. Int J Gynecol Pathol. 1991;10(4):356–63.
Yasui W, Kameda T, Harada D, Nakatani H, Hata J, Ito H, et al. A case of sweat gland carcinoma arising in a mature cystic teratoma of the ovary. Gan No Rinsho. 1987;33(7):875–80.
Morimitsu Y, Nakashima O, Nakashima Y, Kojiro M, Shimokobe T. Apocrine adenocarcinoma arising in cystic teratoma of the ovary. Arch Pathol Lab Med. 1993;117(6):647–9.
Kudo M. The nature of “blue nevus” in cystic teratomas of the ovary. An ultrastructural evidence for Schwann cell origin. Acta Pathol Jpn. 1985;35(3):693–8.
Kuroda N, Hirano K, Inui Y, Yamasaki Y, Toi M, Nakayama H, et al. Compound melanocytic nevus arising in a mature cystic teratoma of the ovary. Pathol Int. 2001;51(11):902–4. doi:1288 [pii]
Tsang P, Berman L, Kasznica J. Adnexal tumor and a pigmented nevoid lesion in a benign cystic ovarian teratoma. Arch Pathol Lab Med. 1993;117(8):846–7.
Amortegui AJ, Kanbour AI. Compound nevus in a cystic teratoma of the ovary. Arch Pathol Lab Med. 1981;105(2):115–6.
Kruger S, Schmidt H, Kupker W, Rath FW, Feller AC. Fibrosarcoma associated with a benign cystic teratoma of the ovary. Gynecol Oncol 2002;84(1):150–4. doi:10.1006/gyno.2001.6408 S009082580196408X [pii].
Stamp GW, McConnell EM. Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol. 1983;90(7):671–5.
Kelley RR, Scully RE. Cancer developing in dermoid cysts of the ovary. A report of 8 cases, including a carcinoid and a leiomyosarcoma. Cancer. 1961;14:989–1000.
Allam-Nandyala P, Bui MM, Caracciolo JT, Hakam A. Squamous cell carcinoma and osteosarcoma arising from a dermoid cyst–a case report and review of literature. Int J Clin Exp Pathol. 2010;3(3):313–8.
Ngwalle KE, Hirakawa T, Tsuneyoshi M, Enjoji M. Osteosarcoma arising in a benign dermoid cyst of the ovary. Gynecol Oncol. 1990;37(1):143–7.
Yasunaga M, Saito T, Eto T, Okadome M, Ariyoshi K, Nishiyama K, et al. Dedifferentiated chondrosarcoma arising in a mature cystic teratoma of the ovary: a case report and review of the literature. Int J Gynecol Pathol. 2011;30(4):391–4. doi:10.1097/PGP.0b013e318211f56e.
Climie AR, Heath LP. Malignant degeneration of benign cystic teratomas of the ovary. Review of the literature and report of a chondrosarcoma and carcinoid tumor. Cancer. 1968;22(4):824–32.
Contreras AL, Malpica A. Angiosarcoma arising in mature cystic teratoma of the ovary: a case report and review of the literature. Int J Gynecol Pathol 2009;28(5):453–7. doi:10.1097/PGP.0b013e31819d4574 00004347-200909000-00006 [pii].
den Bakker MA, Ansink AC, Ewing-Graham PC. “Cutaneous-type” angiosarcoma arising in a mature cystic teratoma of the ovary. J Clin Pathol. 2006;59(6):658–60. doi:59/6/658 [pii] 10.1136/jcp.2005.029751.
Kefeli M, Kandemir B, Akpolat I, Yildirim A, Kokcu A. Rhabdomyosarcoma arising in a mature cystic teratoma with contralateral serous carcinoma: case report and review of the literature. Int J Gynecol Pathol. 2009;28(4):372–5. doi:10.1097/PGP.0b013e3181929269.
Ueda G, Sato Y, Yamasaki M, Inoue M, Hiramatsu K, Tanaka Y, et al. Malignant fibrous histiocytoma arising in a benign cystic teratoma of the ovary. Gynecol Oncol. 1977;5(3):313–22. doi:0090-8258(77)90041-5 [pii].
Richardson G, Robertson DI, O’Connor ME, Nation JG, Stuart GC. Malignant transformation occurring in mature cystic teratomas of the ovary. Can J Surg. 1990;33(6):499–503.
Adams H, Went P, Tolnay M, Sartorius G, Singer G. Meningothelial meningioma in a mature cystic teratoma of the ovary. Pathologe. 2007;28(4):278–80. doi:10.1007/s00292-006-0828-z.
Takeshima Y, Kaneko M, Furonaka O, Jeet AV, Inai K. Meningioma in mature cystic teratoma of the ovary. Pathol Int 2004;54(7):543–8. doi:10.1111/j.1440-1827.2004.01662.x PIN1662 [pii].
Elliot VJ, Shaw EC, Walker M, Jaynes E, Theaker JM. Ovarian paraganglioma arising from mature cystic teratoma. Int J Gynecol Pathol. 2012;31(6):545–6. doi:10.1097/PGP.0b013e31824d3564.
Mahdavi A, Silberberg B, Malviya VK, Braunstein AH, Shapiro J. Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary. Gynecol Oncol. 2003;90(2):482–5. doi:S0090825803002725 [pii].
den Boon J, van Dijk CM, Helfferich M, Peterse HL. Glioblastoma multiforme in a dermoid cyst of the ovary. A case report. Eur J Gynaecol Oncol. 1999;20(3):187–8.
Bjersing L, Cajander S, Rogo K, Ottosson UB, Stendahl U. Glioblastoma multiform in a dermoid cyst of the ovary. Eur J Gynaecol Oncol. 1989;10(6):389–92.
Yadav A, Lellouch-Tubiana A, Fournet JC, Quazza JE, Kalifa C, Sainte-Rose C, et al. Glioblastoma multiforme in a mature ovarian teratoma with recurring brain tumours. Histopathology. 1999;35(2):170–3. doi:his695 [pii].
Spaulding R, Alatassi H, Stewart Metzinger D, Moghadamfalahi M. Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I. Case Rep Obstet Gynecol. 2014;2014:712657. doi:10.1155/2014/712657.
Stolnicu S, Furtado A, Sanches A, Nicolae A, Preda O, Hincu M et al. Ovarian ependymomas of extra-axial type or central immunophenotypes. Hum Pathol 2011;42(3):403–8. doi:10.1016/j.humpath.2010.07.017 S0046-8177(10)00311-4 [pii].
Ud Din N, Memon A, Aftab K, Ahmad Z, Ahmed R, Hassan S. Oligodendroglioma arising in the glial component of ovarian teratomas: a series of six cases and review of literature. J Clin Pathol 2012;65(7):631–4. doi:10.1136/jclinpath-2012-200714 jclinpath-2012-200714 [pii].
Opris I, Ducrotoy V, Bossut J, Lamy A, Sabourin JC. Oligodendroglioma arising in an ovarian mature cystic teratoma. Int J Gynecol Pathol. 2009;28(4):367–71. doi:10.1097/PGP.0b013e318196c4c0.
Skopelitou A, Mitselou A, Michail M, Mitselos V, Stefanou D. Pilocytic astrocytoma arising in a dermoid cyst of the ovary: a case presentation. Virchows Arch. 2002;440(1):105–6.
Wey SL, Chen CK, Chen TC, Chen TY. Desmoplastic medulloblastoma arising from an ovarian teratoma: a case report and review of the literature. Int J Surg Pathol 2013;21(4):427–31. doi:10.1177/1066896912464048 1066896912464048 [pii].
Olah KS, Needham PG, Jones B. Multiple neuroectodermal tumors arising in a mature cystic teratoma of the ovary. Gynecol Oncol. 1989;34(2):222–5. doi:0090-8258(89)90147-9 [pii].
Block M, Gilbert E, Davis C. Metastatic neuroblastoma arising in an ovarian teratoma with long-term survival. Case report and review of the literature. Cancer. 1984;54(3):590–5.
Reid HA, van der Walt JD, Fox H. Neuroblastoma arising in a mature cystic teratoma of the ovary. J Clin Pathol. 1983;36(1):68–73.
Kleinman GM, Young RH, Scully RE. Primary neuroectodermal tumors of the ovary. A report of 25 cases. Am J Surg Pathol. 1993;17(8):764–78.
Aguirre P, Scully RE. Malignant neuroectodermal tumor of the ovary, a distinctive form of monodermal teratoma: report of five cases. Am J Surg Pathol. 1982;6(4):283–92.
Boor PJ, Schoene WC. Fetal cerebellar tissue associated with a primitive neuro-epithelial tumor in an ovarian teratoma. Can J Neurol Sci. 1975;2(2):139–41.
Hirschowitz L, Ansari A, Cahill DJ, Bamford DS, Love S. Central neurocytoma arising within a mature cystic teratoma of the ovary. Int J Gynecol Pathol. 1997;16(2):176–9.
von Gunten M, Burger H, Vajtai I. Choroid plexus papilloma developing in a dermoid cyst of ovary. Histopathology 2006;49(2):204–5. doi:HIS2383 [pii] 10.1111/j.1365-2559.2006.02383.x.
Marquette S, Amant F, Vergote I, Moerman P. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report. Int J Gynecol Pathol 2006;25(4):340–3. doi:10.1097/01.pgp.0000209571.16340.20 00004347-200610000-00005 [pii].
Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol. 2003;27(5):650–7.
Valli R, Froio E, Alvarez de Celis MI, Mandato VD, Piana S. Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation. Hum Pathol 2014;45(12):2507–11. doi:10.1016/j.humpath.2014.09.002 S0046-8177(14)00368-2 [pii].
Gandhi N, Soomro IN, O’Connor S, Sovani V. Primary lymphoma arising in a mature cystic teratoma of the ovary. Histopathology. 2012;61(6):1238–40. doi:10.1111/j.1365-2559.2012.04343.x.
Damiani S. Pulmonary papillary adenoma-like tumour arising in ovarian teratoma. Virchows Arch. 2004;445(1):96–7. doi:10.1007/s00428-004-1022-4.
Ikota H, Kaneko K, Takahashi S, Kawarai M, Tanaka Y, Yokoo H, et al. Malignant transformation of ovarian mature cystic teratoma with a predominant pulmonary type small cell carcinoma component. Pathol Int. 2012;62(4):276–80. doi:10.1111/j.1440-1827.2012.02804.x.
Rubio A, Schuldt M, Chamorro C, Crespo-Lora V, Nogales FF. Ovarian small cell carcinoma of pulmonary type arising in mature cystic teratomas with metastases to the contralateral ovary. Int J Surg Pathol 2015;23(5):388–92. doi:10.1177/1066896915586254 1066896915586254 [pii].
Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Furuya K. Large cell neuroendocrine carcinoma arising in mature cystic teratoma: a case report and review of the literature. Eur J Gynaecol Oncol. 2012;33(4):414–8.
Chenevert J, Bessette P, Plante M, Tetu B, Dube V. Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature. Pathol Res Pract 2009;205(9):657–61. doi:10.1016/j.prp.2009.01.013 S0344-0338(09)00040-5 [pii].
Choi YD, Lee JS, Choi C, Park CS, Nam JH. Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma. Gynecol Oncol 2007;104(3):747–52. doi:S0090-8258(06)00900-0 [pii] 10.1016/j.ygyno.2006.11.008.
Ting WH, Hsiao SM, Lin HH, Wei MC. Primary carcinoid tumor of the ovary arising in a mature cystic teratoma: a case report. Eur J Gynaecol Oncol. 2014;35(1):100–2.
Guney N, Sayilgan T, Derin D, Ozcan D. Primary carcinoid tumor arising in a mature cystic teratoma of the ovary: a case report. Eur J Gynaecol Oncol. 2009;30(2):223–5.
Huang B, Wu X, Zhou Q, Hu Y, Zhao H, Zhu H, et al. Cushing’s syndrome secondary to ectopic ACTH secretion from carcinoid tumor within an ovarian mature teratoma: a case report and review of the literature. Gynecol Endocrinol. 2014;30(3):192–6. doi:10.3109/09513590.2013.871518.
Hsu CY, Yang CF, Chen WY, Chiang H. Adenosquamous carcinoma and schneiderian papilloma-like lesion in a mature cystic teratoma of the ovary: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57(5):375–9.
Las Heras F, Pritzker KP, Colgan TJ. Chordoma arising in a mature cystic teratoma of the ovary: a case report. Pathol Res Pract 2007;203(6):467–71. doi:S0344-0338(07)00031-3 [pii] 10.1016/j.prp.2006.12.010.
Silver SA, Tavassoli FA. Glomus tumor arising in a mature teratoma of the ovary: report of a case simulating a metastasis from cervical squamous carcinoma. Arch Pathol Lab Med. 2000;124(9):1373–5. doi:10.1043/0003-9985(2000)124<1373:GTAIAM>2.0.CO;2.
Genadry R, Parmley T, Woodruff JD. Secondary malignancies in benign cystic teratomas. Gynecol Oncol. 1979;8(2):246–51. doi:0090-8258(79)90032-5 [pii].
Hanada M, Tsujimura T, Shimizu H. Multiple malignancies (squamous cell carcinoma and sarcoma) arising in a dermoid cyst of the ovary. Acta Pathol Jpn. 1981;31(4):681–8.
Leroy C, Gontier MF, Gontier F, Minh HN, Smadja A. Malignant dermoid cyst of the ovary with double tumor cell population, revealed by an umbilical metastasis. Ann Pathol. 1992;12(3):178–82.
Terada T, Tateoka K. Ovarian cystic tumor composed of Brenner tumor and struma ovarii. Int J Clin Exp Pathol. 2012;5(3):274–7.
Nogales FF. Primary chondrosarcoma of the ovary. Histopathology. 1982;6:376.
Nogales Jr FF, Silverberg SG. Epidermoid cysts of the ovary: a report of five cases with histogenetic considerations and ultrastructural findings. Am J Obstet Gynecol. 1976;124(5):523–8.
Isaac MA, Vijayalakshmi S, Madhu CS, Bosincu L, Nogales FF. Pure cystic nephroblastoma of the ovary with a review of extrarenal Wilms’ tumors. Hum Pathol. 2000;31(6):761–4. doi:10.1053/hupa.2000.7627.
Stolnicu S, Preda O, Dohan M, Puscasiu L, Garcia-Galvis OF, Nogales FF. Pseudoglandular hepatoid differentiation in endometrioid carcinoma of the ovary simulates oxyphilic cell change. Int J Gynecol Pathol. 2008;27(4):521–5. doi:10.1097/PGP.0b013e318178e566.
Nogales FF, Concha A, Plata C, Ruiz-Avila I. Granulosa cell tumor of the ovary with diffuse true hepatic differentiation simulating stromal luteinization. Am J Surg Pathol. 1993;17(1):85–90.
Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993;12(4):333–43.
Jin C, Dong R, Bu H, Yuan M, Zhang Y, Kong B. Coexistence of benign struma ovarii, pseudo-Meigs’ syndrome and elevated serum CA 125: case report and review of the literature. Oncol Lett 2015;9(4):1739–42. doi:10.3892/ol.2015.2927 ol-09-04-1739 [pii].
Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475–90. doi:10.1148/radiographics.21.2.g01mr09475.
Moon S, Waxman M. Mixed ovarian tumor composed of Brenner and thyroid elements. Cancer. 1976;38(5):1997–2001.
Yoshida M, Obayashi C, Tachibana M, Minami R. Coexisting Brenner tumor and struma ovarii in the right ovary: case report and review of the literature. Pathol Int 2004;54(10):793–7. doi:PIN1757 [pii] 10.1111/j.1440-1827.2004.01757.x.
Shaco-Levy R, Peng RY, Snyder MJ, Osmond GW, Veras E, Bean SM, et al. Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior. Arch Pathol Lab Med. 2012;136(2):172–8. doi:10.5858/arpa.2011-0092-OA.
Garg K, Soslow RA, Rivera M, Tuttle MR, Ghossein RA. Histologically bland “extremely well differentiated” thyroid carcinomas arising in struma ovarii can recur and metastasize. Int J Gynecol Pathol 2009;28(3):222–30. doi:10.1097/PGP.0b013e31818a2b99 00004347-200905000-00003 [pii].
Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol 2009;28(5):405–22. doi:10.1097/PGP.0b013e3181a27777 00004347-200909000-00001 [pii].
Wolff EF, Hughes M, Merino MJ, Reynolds JC, Davis JL, Cochran CS, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid. 2010;20(9):981–7. doi:10.1089/thy.2009.0458.
Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol. 2007;18(3):182–6. doi:10.1007/s12022-007-0022-8.
Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL et al. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol 2007;31(9):1337–43. doi:10.1097/PAS.0b013e31802f5404 00000478-200709000-00005 [pii].
Reed NS, Gomez-Garcia E, Gallardo-Rincon D, Barrette B, Baumann K, Friedlander M et al. Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. Int J Gynecol Cancer 2014;24(9 Suppl 3):S35–41. doi:10.1097/IGC.0000000000000265 00009577-201411003-00009 [pii].
Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res. 2000;19(3):271–80.
Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013;44(11):2536–41. doi:10.1016/j.humpath.2013.06.014.
Davis KP, Hartmann LK, Keeney GL, Shapiro H. Primary ovarian carcinoid tumors. Gynecol Oncol 1996;61(2):259–65. doi:S0090-8258(96)90136-5 [pii] 10.1006/gyno.1996.0136.
Goldman T, Adamson K, Yang E. Resolution of right-sided heart failure symptoms after resection of a primary ovarian carcinoid tumor. Tex Heart Inst J. 2014;41(5):533–6. doi:10.14503/THIJ-13-3314.
Dessauvagie BF, Lai PH, Oost E, Thomas A, Stewart CJ. Medial hypertrophy of the ovarian vein: a novel type of vascular pathology associated with a primary ovarian carcinoid tumor. Int J Gynecol Pathol. 2015;34(1):36–9. doi:10.1097/PGP.0000000000000114.
Muller KE, Tafe LJ, Gonzalez JL, West LA, Schned AR. Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol. 2015;34(1):30–5. doi:10.1097/PGP.0000000000000117.
Robboy SJ. Insular carcinoid of ovary associated with malignant mucinous tumors. Cancer. 1984;54(10):2273–6.
Mandai M, Konishi I, Tsuruta Y, Suginami N, Kusakari T, Iwasaki T, et al. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2001;97(1):90–5.
Baker PM, Oliva E, Young RH, Talerman A, Scully RE. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases. Am J Surg Pathol. 2001;25(5):557–68.
Armes JE, Ostor AG. A case of malignant strumal carcinoid. Gynecol Oncol 1993;51(3):419–23. doi:S0090-8258(83)71316-8 [pii] 10.1006/gyno.1993.1316.
Kimura N, Sasano N, Namiki T. Evidence of hybrid cell of thyroid follicular cell and carcinoid cell in strumal carcinoid. Int J Gynecol Pathol. 1986;5(3):269–77.
Scully RE. Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer. 1953;6(3):455–63.
Hertel JD, Huettner PC, Dehner LP, Pfeifer JD. The chromosome Y-linked testis-specific protein locus TSPY1 is characteristically present in gonadoblastoma. Hum Pathol. 2010;41(11):1544–9. doi:10.1016/j.humpath.2010.04.007.
Ulbright TM, Young RH. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development. Semin Diagn Pathol 2014;31(5):427–40. doi:10.1053/j.semdp.2014.07.001 S0740-2570(14)00064-1 [pii].
Scully RE. Gonadoblastoma. A review of 74 cases. Cancer. 1970;25(6):1340–56.
Schiller PJ, Tagatz GE. Gonadal calcification. Indication for gonadectomy in gonadal dysgenesis. Obstet Gynecol. 1976;48(4):486–90.
Manivel JC, Dehner LP, Burke B. Ovarian tumorlike structures, biovular follicles, and binucleated oocytes in children: their frequency and possible pathologic significance. Pediatr Pathol. 1988;8(3):283–92.
Serment H, Laffargue P, Piana L, Blanc B. Tumeurs endocrines de l’ovaire chez l’enfant. Rev Fr Gynecol Obstet. 1970;65(9):465–77.
Talerman A. A distinctive gonadal neoplasm related to gonadoblastoma. Cancer. 1972;30(5):1219–24.
Michal M, Vanecek T, Sima R, Mukensnabl P, Hes O, Kazakov DV, et al. Mixed germ cell sex cord-stromal tumors of the testis and ovary. Morphological, immunohistochemical, and molecular genetic study of seven cases. Virchows Arch. 2006;448(5):612–22. doi:10.1007/s00428-006-0155-z.
Talerman A, Roth LM. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives. Int J Gynecol Pathol. 2007;26(3):313–21. doi:10.1097/01.pgp.0000250148.52215.ce.
Roth LM, Cheng L. Expression of transcription factors and nuclear receptors in mixed germ cell-sex cord stromal tumor and related tumors of the gonads. Int J Gynecol Pathol. 2015; doi:10.1097/PGP.0000000000000192.
Arroyo JG, Harris W, Laden SA. Recurrent mixed germ cell-sex cord-stromal tumor of the ovary in an adult. Int J Gynecol Pathol. 1998;17(3):281–3.
Lacson AG, Gillis DA, Shawwa A. Malignant mixed germ-cell-sex cord-stromal tumors of the ovary associated with isosexual precocious puberty. Cancer. 1988;61(10):2122–33.
Tokuoka S, Aoki Y, Hayashi Y, Yokoyama T, Ishii T. A mixed germ cell-sex cord-stromal tumor of the ovary with retiform tubular structure: a case report. Int J Gynecol Pathol. 1985;4(2):161–70.
Tavassoli FA. A combined germ cell–gonadal stromal–epithelial tumor of the ovary. Am J Surg Pathol. 1983;7(1):73–84.
Zuntova A, Motlik K, Horejsi J, Eckschlager T. Mixed germ cell-sex cord stromal tumor with heterologous structures. Int J Gynecol Pathol. 1992;11(3):227–33.
Jacobsen GK, Braendstrup O, Talerman A. Bilateral mixed germ cell sex-cord stroma tumour in a young adult woman. Case Rep APMIS Suppl. 1991;23:132–7.
Bhathena D, Haning Jr RV, Shapiro S, Hafez GR. Coexistence of a gonadoblastoma and mixed germ cell-sex cord stroma tumor. Pathol Res Pract. 1985;180(2):203–8. doi:10.1016/S0344-0338(85)80171-0.
Colafranceschi M, Massi D. Gonadoblastoma with coexistent features of mixed germ cell-sex cord stroma tumor: a case report. Tumori. 1995;81(3):215–8.
Mooney EE, Nogales FF, Bergeron C, Tavassoli FA. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology. 2002;41(2):110–7.
Cabanne F. Gonadoblastomes et tumeurs de l ’ebauche gonadique. Ann Anat Pathol (Paris). 1971;16(4):387–404.
Pflüger E. Ueber die Bewegungen der Ovarien. Archiv für Anatomie, Physiologie und wissenschaftliche Medicin. 1859;S:30–2.
Pang S, Zhang L, Shi Y, Liu Y. Unclassified mixed germ cell-sex cord-stromal tumor with multiple malignant cellular elements in a young woman: a case report and review of the literature. Int J Clin Exp Pathol. 2014;7(8):5259–66.
Shanmugaratnam K, Kunaratnam N, Chia KB, Chiang GS, Sinniah R. Teratoid carcinosarcoma of the paranasal sinuses. Pathology. 1983;15(4):413–9.
Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, et al. Histologic and immunohistochemical analyses of alpha-fetoprotein–producing cancer of the stomach. Am J Surg Pathol. 2012;36(1):56–65. doi:10.1097/PAS.0b013e31823aafec.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014.
http://ec.europa.eu/eurostat/statistics-explained/index.php/Population_structure_and_ageing. Accessed: December 2016.
Praxis Strategy Group Analysis of U.S. Census Population Projections, https://www.census.gov/population/projections/data/national/2014.html.
Lankerani MR, Aubrey RW, Reid JD. Endometriosis of the colon with mixed “germ cell” tumor. Am J Clin Pathol. 1982;78(4):555–9.
Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum Pathol. 1987;18(12):1296–9.
OF G-G, Cabrera-Ozoria C, Fernandez JA, Stolnicu S, Nogales FF. Malignant mullerian mixed tumor of the ovary associated with yolk sac tumor, neuroepithelial and trophoblastic differentiation (teratoid carcinosarcoma). Int J Gynecol Pathol. 2008;27(4):515–20. doi:10.1097/PGP.0b013e31817b06c7.
Varia M, McCluggage WG, Oommen R. High grade serous carcinoma of the ovary with a yolk sac tumour component in a postmenopausal woman: report of an extremely rare phenomenon. J Clin Pathol. 2012;65(9):853–4. doi:10.1136/jclinpath-2011-200606.
Lopez JM, Malpica A, Deavers MT, Ayala AG. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003;7(5):300–5. doi:S1092913403000819 [pii].
Retamero JA, Schuldt M, Nogales FF. Yolk Sac tumours arising from Endometrioid carcinoma of the ovary and endometrium. A review of 14 cases. AJSP Reviews Reports. 2016;(in press).
McNamee T, Damato S, McCluggage WG. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours. Histopathology. 2016;69(5):739–51. doi:10.1111/his.13021.
Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014;33(5):492–9. doi:10.1097/PGP.0b013e3182a54afa.
Teilum G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat’s placenta. Cancer. 1959;12:1092–105.
Offman SL, Longacre TA. Clear cell carcinoma of the female genital tract (not everything is as clear as it seems). Adv Anat Pathol. 2012;19(5):296–312. doi:10.1097/PAP.0b013e31826663b1.
Maeda D, Ota S, Takazawa Y, Aburatani H, Nakagawa S, Yano T, et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol. 2009;22(6):824–32. doi:10.1038/modpathol.2009.40.
Ballotta MR, Bianchini E, Borghi L, Fortini RM. Clear cell carcinoma simulating the “endometrioid-like variant” of yolk sac tumor. Pathologica. 1995;87(1):87–90.
Cetin A, Bahat Z, Cilesiz P, Demirbag N, Yavuz E. Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report. Eur J Gynaecol Oncol. 2007;28(3):241–4.
El-Bahrawy M. Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract. Eur J Cancer. 2010;46(8):1317–22. doi:10.1016/j.ejca.2010.01.028.
Meguro S, Yasuda M. alpha-Fetoprotein-producing ovarian tumor in a postmenopausal woman with germ cell differentiation. Ann Diagn Pathol. 2013;17(1):140–4. doi:10.1016/j.anndiagpath.2011.07.010.
Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, et al. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma–diagnostic utility of HNF-1beta and oestrogen receptor. Histopathology. 2014;64(4):585–96. doi:10.1111/his.12286.
Ramalingam P, Malpica A, Silva EG, Liu JL, Gershenson DM, Deavers MT. The use of cytokeratin 7 in differentiating yolk sac tumors from endometrioid and clear cell carcinomas of the ovary. Lab Investig. 2003;83(1):207A–A.
Iwamoto M, Nakatani Y, Fugo K, Kishimoto T, Kiyokawa T. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. Hum Pathol. 2015;46(7):957–62. doi:10.1016/j.humpath.2015.03.008.
Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32(10):1566–71. doi:10.1097/PAS.0b013e31816d71ad.
Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, et al. Gene expression patterns in ovarian carcinomas. Mol Biol Cell. 2003;14(11):4376–86. doi:10.1091/mbc.E03-05-0279.
Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34(4):533–40. doi:10.1097/PAS.0b013e3181d1dcdd.
Iwanaga S, Shimada A, Hasuo Y, Yoh S, Miyajima S, Nishimura H, et al. Immature teratoma of the uterine fundus. Kurume Med J. 1993;40(3):153–8.
Ansah-Boateng Y, Wells M, Poole DR. Coexistent immature teratoma of the uterus and endometrial adenocarcinoma complicated by gliomatosis peritonei. Gynecol Oncol. 1985;21(1):106–10.
Yu XJ, Zhang L, Liu ZP, Shi YQ, Liu YX. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman. Int J Clin Exp Pathol. 2014;7(12):8996–9001.
Nogales FF, Schuldt M, Prat J. Germ cell tumour patterns occurring in somatic malignacies of the female genital tract. 2016.
Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, et al. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Mullerian tumor). Stem Cells. 2011;29(10):1485–95. doi:10.1002/stem.711.
Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, et al. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res. 2009;15(13):4299–311. doi:10.1158/1078-0432.CCR-08-1883.
Chang SJ, Wang TY, Tsai CY, Hu TF, Chang MD, Wang HW. Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma. BMC Genomics. 2009;10:613. doi:10.1186/1471-2164-10-613.
Gotte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schuring AN, et al. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol. 2008;215(3):317–29. doi:10.1002/path.2364.
Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. Gynecol Oncol. 2015;137(2):299–305. doi:10.1016/j.ygyno.2014.12.005.
Virant-Klun I, Rozman P, Cvjeticanin B, Vrtacnik-Bokal E, Novakovic S, Rulicke T, et al. Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes. Stem Cells Dev. 2009;18(1):137–49. doi:10.1089/scd.2007.0238.
Wang WC, Lee MS, Ko JL, Lai YC. Origin of uterine teratoma differs from that of ovarian teratoma: a case of uterine mature cystic teratoma. Int J Gynecol Pathol 2011;30(6):544–8. doi:10.1097/PGP.0b013e31821c3205 00004347-201111000-00006 [pii].
Siddon A, Hui P. Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin. Int J Gynecol Pathol. 2010;29(4):394–7. doi:10.1097/PGP.0b013e3181c5a7e8.
Newton 3rd CW, Abell MR. Iatrogenic fetal implants. Obstet Gynecol. 1972;40(5):686–91.
Russell P, de Costa C, Yeoh G. Fetal glial allograft in the endometrium: case report of a recurrent pseudo-tumor. Pathology. 1993;25(3):247–9.
Chao TJ, Chao J, Kuan LJ, Li YT, Kuo TC, Chang YC, et al. Mature solid teratoma of the fallopian tube associated with uterine leiomyomas. J Chinese Med Assoc. 2008;71(8):425–7. doi:10.1016/s1726-4901(08)70095-9.
Kutteh WH, Albert T. Mature cystic teratoma of the fallopian tube associated with an ectopic pregnancy. Obstet Gynecol. 1991;78(5 Pt 2):984–6.
Hurd Jr JK. Benign cystic teratoma of the fallopian tube. Obstet Gynecol. 1978;52(3):362–4.
Frost RG, Roongpisuthipong A, Cheek BH, Majmudar BN. Immature teratoma of the fallopian tube. A case report. J Reprod Med. 1989;34(1):62–4.
Papadia A, Rutigliani M, Gerbaldo D, Fulcheri E, Ragni N. Mature cystic teratoma of the uterus presenting as an endometrial polyp. Ultrasound Obstet Gynecol. 2007;29(4):477–8. doi:10.1002/uog.3969.
Takahashi O, Shibata S, Hatazawa J, Takisawa J, Sato H, Ota H, et al. Mature cystic teratoma of the uterine corpus. Acta Obstet Gynecol Scand. 1998;77(9):936–8.
Kamgobe E, Massinde A, Matovelo D, Ndaboine E, Rambau P, Chaula T. Uterine myometrial mature teratoma presenting as a uterine mass: a review of literature. BMC Clin Pathol. 2016;16:5. doi:10.1186/s12907-016-0026-8.
Akai M, Isoda H, Sawada S, Matsuo I, Kanzaki H, Sakaida N, et al. A case of struma uteri. AJR Am J Roentgenol. 2005;185(1):216–8. doi:10.2214/ajr.185.1.01850216.
Newsom-Davis T, Poulter D, Gray R, Ameen M, Lindsay I, Papanikolaou K et al. Case report: malignant teratoma of the uterine corpus. BMC Cancer 2009;9:195. doi:10.1186/1471-2407-9-195 1471-2407-9-195 [pii].
Lim SC, Kim YS, Lee YH, Lee MS, Lim JY. Mature teratoma of the uterine cervix with lymphoid hyperplasia. Pathol Int. 2003;53(5):327–31. doi:1468 [pii].
Iwanaga S, Ishii H, Nagano H, Shimizu M, Nishida T, Yakushiji M. Mature cystic teratoma of the uterine cervix. Asia Oceania J Obstet Gynaecol. 1990;16(4):363–6.
Panesar NK, Sidhu JS. Uterine cervical teratoma with divergent neuroepithelial differentiation and development of an oligodendroglioma: report of a case and review of the literature. Ann Diagn Pathol. 2007;11(4):293–6. doi:10.1016/j.anndiagpath.2006.03.019.
Spatz A, Bouron D, Pautier P, Castaigne D, Duvillard P. Primary yolk sac tumor of the endometrium: a case report and review of the literature. Gynecol Oncol 1998;70(2):285–8. doi:S0090-8258(98)95036-3 [pii] 10.1006/gyno.1998.5036.
Wang C, Li G, Xi L, Gu M, Ma D. Primary yolk sac tumor of the endometrium. Int J Gynaecol Obstet 2011;114(3):291–3. doi:10.1016/j.ijgo.2011.03.020 S0020-7292(11)00259-1 [pii].
Mardi K, Gupta N, Bindra R. Primary yolk sac tumor of cervix and vagina in an adult female: a rare case report. Indian J Cancer. 2011;48(4):515–6. doi:10.4103/0019-509X.92249 IndianJournalofCancer_2011_48_4_515_92249 [pii].
Mochizuki K, Obatake M, Taura Y, Inamura Y, Takatsuki M, Nagayasu T, et al. Yolk sac tumor of the vulva: a case report with recurrence after long-term follow-up. Pediatr Surg Int. 2012;28(9):931–4. doi:10.1007/s00383-012-3153-z.
Flanagan CW, Parker JR, Mannel RS, Min KW, Kida M. Primary endodermal sinus tumor of the vulva: a case report and review of the literature. Gynecol Oncol 1997;66(3):515–8. doi:S0090-8258(97)94759-4 [pii] 10.1006/gyno.1997.4759.
Mamoon N, Mushtaq S, Akhter N, Aslam A, Chaudary A, Rashid M. Immature teratoma of the vulva with an inguinal lymph node metastasis: report of a case and review of literature. Int J Gynecol Pathol 2010;29(2):197–200. doi:10.1097/PGP.0b013e3181b8e73e 00004347-201003000-00015 [pii].
Acknowledgments
The authors are grateful to the following pathologists for kindly providing the cases illustrating the following figures:
Figure 6-3B. Dr. Isabel Alvarado-Cabrero, Hospital Siglo XXI, Mexico DF, Mexico
Figure 6-6B. Dr. Carmen Tornos, Stony Brook University, NY. USA
Figure 6-6R. Dr. Silvia Chiarelli, Università degli Studi di Padova. Italy
Figure 6-6S. Dr. Harry Hollema, University of Groningen. The Netherlands
Figure 6-20A. Dr. Miguel Marin-Padilla, Geisel School of Medicine at Dartmouth, Hanover, NH, USA
Figure 6-23B. Dr. Lara Alberte, CHUVI Vigo, Spain
Figure 6-30. Dr. Baljeet Kaur. Hammersmith Hospital, London, UK
Figure6-31. Dr. Maria J Pareja.Complejo Hospitalario Universitario de Huelva, Spain
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Germany
About this chapter
Cite this chapter
Nogales, F.F., Schuldt, M. (2017). Germ Cell Tumors of the Female Genital Tract. In: Nogales, F., Jimenez, R. (eds) Pathology and Biology of Human Germ Cell Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53775-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-53775-6_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53773-2
Online ISBN: 978-3-662-53775-6
eBook Packages: MedicineMedicine (R0)